564 lines
No EOL
123 KiB
XML
564 lines
No EOL
123 KiB
XML
<?xml version="1.0" encoding="utf-8"?>
|
||
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
|
||
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
|
||
|
||
<head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
|
||
<!-- AppResources meta begin -->
|
||
<meta name="paf-app-resources" content="" />
|
||
<script type="text/javascript">var ncbi_startTime = new Date();</script>
|
||
|
||
<!-- AppResources meta end -->
|
||
|
||
<!-- TemplateResources meta begin -->
|
||
<meta name="paf_template" content="" />
|
||
|
||
<!-- TemplateResources meta end -->
|
||
|
||
<!-- Logger begin -->
|
||
<meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-toc" /><meta name="ncbi_acc" content="NBK589578" /><meta name="ncbi_domain" content="niceng219er1" /><meta name="ncbi_report" content="printable" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK589578/?report=printable" /><meta name="ncbi_app" content="bookshelf" />
|
||
<!-- Logger end -->
|
||
|
||
<title>Evidence review for patient information - NCBI Bookshelf</title>
|
||
|
||
<!-- AppResources external_resources begin -->
|
||
<link rel="stylesheet" href="/core/jig/1.15.2/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.15.2/js/jig.min.js"></script>
|
||
|
||
<!-- AppResources external_resources end -->
|
||
|
||
<!-- Page meta begin -->
|
||
<meta name="robots" content="INDEX,FOLLOW,NOARCHIVE,NOIMAGEINDEX" /><meta name="citation_title" content="Evidence review for patient information" /><meta name="citation_publisher" content="National Institute for Health and Care Excellence (NICE)" /><meta name="citation_date" content="2022/06" /><meta name="citation_pmid" content="36921074" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK589578/" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="Evidence review for patient information" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="National Institute for Health and Care Excellence (NICE)" /><meta name="DC.Date" content="2022/06" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK589578/" /><meta name="og:title" content="Evidence review for patient information" /><meta name="og:type" content="book" /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK589578/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-niceng219er1-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/niceng219er1/toc/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK589578/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.26/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.26/css/books_print.min.css" type="text/css" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace} .first-line-outdent .bk_ref {display: inline} </style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js?_=3.18"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.26/books.min.js"> </script>
|
||
|
||
<!-- Page meta end -->
|
||
<link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE8E37DA7D6DD1D10000000000B60093.m_5" />
|
||
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4216699/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4216701/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/3984801/12930/3964959.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4216699/css/3411343/3882866.css" media="print" /></head>
|
||
<body class="book-toc">
|
||
<div class="grid no_max_width">
|
||
<div class="col twelve_col nomargin shadow">
|
||
<!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
|
||
<div class="sysmessages">
|
||
<noscript>
|
||
<p class="nojs">
|
||
<strong>Warning:</strong>
|
||
The NCBI web site requires JavaScript to function.
|
||
<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
|
||
</p>
|
||
</noscript>
|
||
</div>
|
||
<!--/.sysmessage-->
|
||
<div class="wrap">
|
||
<div class="page">
|
||
<div class="top">
|
||
|
||
<div class="header">
|
||
|
||
|
||
</div>
|
||
|
||
|
||
|
||
<!--<component id="Page" label="headcontent"/>-->
|
||
|
||
</div>
|
||
<div class="content">
|
||
<!-- site messages -->
|
||
<div class="container content">
|
||
<div class="source">
|
||
<div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p></div></div></div>
|
||
<div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/Book"><div class="meta-content fm-sec"><div class="iconblock whole_rhythm clearfix no_top_margin"><a href="https://www.nice.org.uk" title="National Institute for Health and Care Excellence (NICE)" class="img_link icnblk_img" ref="pagearea=logo&targetsite=external&targetcat=link&targettype=publisher"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-niceng219er1-lrg.png" alt="Cover of Evidence review for patient information" /></a><div class="icnblk_cntnt"><h1 id="_NBK589578_"><span itemprop="name">Evidence review for patient information</span></h1><div class="subtitle">Gout: diagnosis and management</div><p><b>Evidence review A</b></p><p><i>NICE Guideline, No. 219</i></p><div class="half_rhythm">London: <a href="https://www.nice.org.uk" ref="pagearea=meta&targetsite=external&targetcat=link&targettype=publisher"><span itemprop="publisher">National Institute for Health and Care Excellence (NICE)</span></a>; <span itemprop="datePublished">2022 Jun</span>.<div class="small">ISBN-13: <span itemprop="isbn">978-1-4731-4603-7</span></div></div><div><a href="/books/about/copyright/">Copyright</a> © NICE 2022.</div></div></div></div><div class="body-content whole_rhythm" itemprop="text"><div id="niceng219er1.s1"><h2 id="_niceng219er1_s1_">1. Patient information</h2><div id="niceng219er1.s1.1"><h3>1.1. Review question: What information and support is needed by people with gout and their families or carers in relation to gout, and when should this be provided?</h3><div id="niceng219er1.s1.1.1"><h4>1.1.1. Introduction</h4><p>People with gout (and their families and carers) require information that explains the causes, diagnosis, treatment and self-management options including dietary advice to support active participation in their care and engage in shared decision making.</p><p>As gout is a long-term condition, ongoing support may be required not only during acute episodes, but also to ensure the efficacy of life-long drug treatment such as urate lowering therapy. In current practice the provision of information and support varies widely and dependent on many factors including the knowledge and time available to the clinician.</p><p>This evidence review evaluates the information and support needs of people with gout and their families or carers and when this should be provided.</p></div><div id="niceng219er1.s1.1.2"><h4>1.1.2. Summary of the protocol</h4><p>For full details see the review protocol in <a href="#niceng219er1.appa">Appendix A</a>.</p></div><div id="niceng219er1.s1.1.3"><h4>1.1.3. Methods and process</h4><p>This evidence review was developed using the methods and process described in <a href="https://www.nice.org.uk/process/pmg20/chapter/introduction-and-overview" ref="pagearea=body&targetsite=external&targetcat=link&targettype=uri">Developing NICE guidelines: the manual</a>. Methods specific to this review question are described in the review protocol in <a href="#niceng219er1.appa">Appendix A</a> and the methods document.</p><p>Declarations of interest were recorded according to <a href="https://www.nice.org.uk/about/who-we-are/policies-and-procedures" ref="pagearea=body&targetsite=external&targetcat=link&targettype=uri">NICE’s conflicts of interest policy</a>.</p></div><div id="niceng219er1.s1.1.4"><h4>1.1.4. Qualitative evidence</h4><div id="niceng219er1.s1.1.4.1"><h5>1.1.4.1. Included studies</h5><p>We searched for qualitative studies looking at information and support needed by people with gout and their families or carers and when this should be provided.</p><p>Eighteen qualitative studies were included in the review <a class="bk_pop" href="#niceng219er1.ref2"><sup>2</sup></a><sup>,</sup>
|
||
<a class="bk_pop" href="#niceng219er1.ref3"><sup>3</sup></a><sup>,</sup>
|
||
<a class="bk_pop" href="#niceng219er1.ref7"><sup>7</sup></a><sup>,</sup>
|
||
<a class="bk_pop" href="#niceng219er1.ref13"><sup>13</sup></a><sup>,</sup>
|
||
<a class="bk_pop" href="#niceng219er1.ref15"><sup>15</sup></a><sup>–</sup><a class="bk_pop" href="#niceng219er1.ref17"><sup>17</sup></a><sup>,</sup>
|
||
<a class="bk_pop" href="#niceng219er1.ref26"><sup>26</sup></a><sup>,</sup>
|
||
<a class="bk_pop" href="#niceng219er1.ref27"><sup>27</sup></a><sup>,</sup>
|
||
<a class="bk_pop" href="#niceng219er1.ref29"><sup>29</sup></a><sup>,</sup>
|
||
<a class="bk_pop" href="#niceng219er1.ref40"><sup>40</sup></a><sup>–</sup><a class="bk_pop" href="#niceng219er1.ref42"><sup>42</sup></a><sup>,</sup>
|
||
<a class="bk_pop" href="#niceng219er1.ref46"><sup>46</sup></a><sup>,</sup>
|
||
<a class="bk_pop" href="#niceng219er1.ref53"><sup>53</sup></a><sup>,</sup>
|
||
<a class="bk_pop" href="#niceng219er1.ref56"><sup>56</sup></a><sup>,</sup>
|
||
<a class="bk_pop" href="#niceng219er1.ref58"><sup>58</sup></a><sup>,</sup>
|
||
<a class="bk_pop" href="#niceng219er1.ref59"><sup>59</sup></a>. These are summarised in <a class="figpopup" href="/books/NBK589578/table/niceng219er1.tab2/?report=objectonly" target="object" rid-figpopup="figniceng219er1tab2" rid-ob="figobniceng219er1tab2">Table 2</a> below.</p><p>Three studies<a class="bk_pop" href="#niceng219er1.ref27"><sup>27</sup></a><sup>,</sup>
|
||
<a class="bk_pop" href="#niceng219er1.ref41"><sup>41</sup></a><sup>,</sup>
|
||
<a class="bk_pop" href="#niceng219er1.ref42"><sup>42</sup></a> conducted separate qualitative analyses using data from one population of patients, therefore we have amalgamated these three studies within this review.</p><p>Most of the studies used semi-structured interviews with a mixture of grounded theory or thematic analysis. One study<a class="bk_pop" href="#niceng219er1.ref56"><sup>56</sup></a> used the Kaupapa Maori approach. One study<a class="bk_pop" href="#niceng219er1.ref2"><sup>2</sup></a> used focus groups.</p><p>Key findings from these studies are summarised in the clinical evidence summary below <a class="figpopup" href="/books/NBK589578/table/niceng219er1.tab2/?report=objectonly" target="object" rid-figpopup="figniceng219er1tab2" rid-ob="figobniceng219er1tab2">Table 2</a>. See also the study selection flow chart in <a href="#niceng219er1.appc">Appendix C</a> study evidence tables in <a href="#niceng219er1.appd">Appendix D</a>, and excluded studies lists in <a href="#niceng219er1.appf">Appendix F</a>.</p><p>Studies included populations with gout on different treatments. Four studies included a population in an area with a higher prevalence of gout (Humphrey 2016),<a class="bk_pop" href="#niceng219er1.ref16"><sup>16</sup></a> (Martini, 2012),<a class="bk_pop" href="#niceng219er1.ref29"><sup>29</sup></a> (Rebello, 2016),<a class="bk_pop" href="#niceng219er1.ref40"><sup>40</sup></a> (Te Karu, 2013).<a class="bk_pop" href="#niceng219er1.ref56"><sup>56</sup></a> Most studies interviewed patients with gout or their partners, however some studies examined the experience and views of health care professionals.</p><p>One study examined patient perceptions of a nurse-led package of care (Latif, 2019)<a class="bk_pop" href="#niceng219er1.ref26"><sup>26</sup></a> One study interviewed pharmacists (Counsell, 2018)<a class="bk_pop" href="#niceng219er1.ref3"><sup>3</sup></a>, four studies interviewed GPs or as part of a mixed group Jeyaruban, 2016,<a class="bk_pop" href="#niceng219er1.ref17"><sup>17</sup></a> Vaccher, 2016<a class="bk_pop" href="#niceng219er1.ref58"><sup>58</sup></a>, Humphrey, 2016<a class="bk_pop" href="#niceng219er1.ref16"><sup>16</sup></a> and Spencer, 2012.<a class="bk_pop" href="#niceng219er1.ref53"><sup>53</sup></a> Two studies recruited patients from other studies (Howren 2018)<a class="bk_pop" href="#niceng219er1.ref15"><sup>15</sup></a> which included patients who were participating in an eHealth supported collaborative care study (Virtual Gout Study) and Latif 2019<a class="bk_pop" href="#niceng219er1.ref26"><sup>26</sup></a> which included patients from the nurse-led care arm of an RCT.</p><p>As a lot of papers were identified for this review, inclusion was halted once saturation was reached. Saturation is the point at which no new information emerged from studies that were found to match the review protocol.</p><p>A narrative summary of the evidence synthesis is provided in <a class="figpopup" href="/books/NBK589578/table/niceng219er1.tab3/?report=objectonly" target="object" rid-figpopup="figniceng219er1tab3" rid-ob="figobniceng219er1tab3">Table 3</a>.</p></div><div id="niceng219er1.s1.1.4.2"><h5>1.1.4.2. Excluded studies</h5><p>See <a href="#niceng219er1.appf">Appendix F</a> for details of excluded studies.</p></div></div><div id="niceng219er1.s1.1.5"><h4>1.1.5. Summary of studies included in the qualitative evidence</h4><p>See <a href="#niceng219er1.appd">Appendix D</a> for full evidence tables.</p></div><div id="niceng219er1.s1.1.6"><h4>1.1.6. Summary of the qualitative evidence</h4><p>See <a href="#niceng219er1.appe">Appendix E</a> for full GRADE-CERQual tables.</p><div id="niceng219er1.s1.1.6.1"><h5>Narrative summary of review findings</h5><div id="niceng219er1.s1.1.6.1.1"><h5>Review finding 1: Patient knowledge of causes of gout</h5><p>The causes of gout were in general poorly understood by patients. Despite many patients having a family history of the condition, very few believed there to be a genetic link. Some stated they had no idea of possible causes. There was also a lack of knowledge in relation to medication and renal factors linked to gout.</p><p>The lack of understanding of the causes of the disease created some doubt about the diagnosis. There was a general view that it was self-inflicted and therefore ‘not a disease’ and this caused people to hesitate in seeking medical help.</p><p>Explanation of quality assessment: minor methodological limitations in six of the eight contributing studies due to the unclear role of the researcher and moderate limitations in two studies due to the recruitment process and data analysis; no concerns about the coherence of the finding with nothing to lower our confidence; no concerns about relevance; no concerns about inadequacy as the evidence is sufficiently deep (provide themes, with elaborations and examples). There was a judgement of moderate/ high confidence in this finding.</p></div><div id="niceng219er1.s1.1.6.1.2"><h5>Review finding 2: Patient knowledge of dietary advice</h5><p>Many patients were unsure of dietary advice citing a variety of beliefs on the subject, as found in the causes of gout theme, the lack of knowledge of pathophysiology of the disease gave rise to confusion about dietary triggers. Diet was a frequent topic for discussion, particularly at GP appointments. Published information provided was not always clear and sometimes in contradiction to verbal information given by HCPs. Patients especially wanted to know what their personal triggers where, and how to cope with eating outside of the home.</p><p>Explanation of quality assessment: minor or very minor methodological limitations in five of the seven studies due to the unclear role of the researcher and moderate limitations in two due to the recruitment process and data analysis and one study with moderate concerns about the role of the researcher.; no concerns about the coherence of the finding with nothing to lower our confidence; no concerns about relevance; no concerns about inadequacy as the evidence is sufficiently deep (provide themes, with elaborations and examples). There was a judgement of moderate/ high confidence in this finding.</p></div><div id="niceng219er1.s1.1.6.1.3"><h5>Review finding 3: Long-term impact of gout</h5><p>Many GPs focussed on acute attacks and acknowledged that they do not give enough information on the possible long-term consequences of gout, and this leads many patients to be unaware of the chronic nature of the disease. Some GPs appeared reluctant to prescribe allopurinol, citing reasons such as it was better to wait until the patient experience a flare, or that it could cause a flare. Nurses and partners of patients with gout highlighted the need for a better understanding of ULT. Patients who did take ULT often discontinued early as they were unaware of its preventative nature. Compliance with preventative medication appeared to improve when patients were made aware of the long-term issues and possible complications. Patients also expressed a desire to know more about long-term medication.</p><p>Explanation of quality assessment: minor or very minor methodological limitations in the contributing studies; no concerns about the coherence of the finding with nothing to lower our confidence; no concerns about relevance due to some contributing studies; no concerns about inadequacy as the evidence is sufficiently deep (provide themes, with elaborations and examples). There was a judgement of high confidence in this finding.</p></div><div id="niceng219er1.s1.1.6.1.4"><h5>Review finding 4: Tailored information specifically for females</h5><p>Often, women with symptoms suggestive of gout were dismissed due to their gender, or their age. This caused delays in diagnosis. There was also not much information specifically tailored to females available. There was a general belief among patients and HCPs that women did not suffer from gout, leading to patients believing that there was something else wrong with them. Female patients wanted information tailored to them and wanted to know how medications could affect female specific issues.</p><p>Explanation of quality assessment: minor methodological limitations in the contributing studies; no concerns about the coherence of the finding with nothing to lower our confidence; no concerns about relevance; no concerns about inadequacy as the evidence is sufficiently deep (provide themes, with elaborations and examples). There was a judgement of high confidence in this finding.</p></div><div id="niceng219er1.s1.1.6.1.5"><h5>Review finding 5: Online sources of information</h5><p>Patients mainly stated that the first thing they did after receiving the diagnosis was to check for more information online. While many websites, NHS and others provided helpful information, and patient forums provided a sense of community, patients frequently found conflicting, incorrect, or ambiguous advice. Some patients found the information they retrieved alarming. As a consequence, some patients changed their diets based on online advice and even bought monitoring equipment.</p><p>Explanation of quality assessment: minor methodological limitations seven of the eight contributing studies, with the exception of moderate concerns in one study due to recruitment and data analysis; no concerns about the coherence of the finding with nothing to lower our confidence; no concerns about relevance; no concerns about inadequacy as the evidence is sufficiently deep (provide themes, with elaborations and examples). There was a judgement of moderate/ high confidence in this finding.</p></div><div id="niceng219er1.s1.1.6.1.6"><h5>Review finding 6: Information/ education preferences</h5><p>Some HCPs wrongly assume patients know more about the gout than they do, due to it being a well-known condition. Many patients found the information provided contradictory and difficult to follow. Most people got their information from their GP, although some mentioned receiving information from their pharmacist. Most asked for extra information, and preferred written information that they could read at home with their family or carers. This was especially true in cases where the GP did not speak the patient’s first language. When oral advice was given, it was difficult for patients to recall. Some people highlighted that information using pictures was particularly helpful.</p><p>Many patients stated that at the point of diagnosis, they would like to have enough time to discuss the implications of their condition and receive information on medication and diet.</p><p>Explanation of quality assessment: minor methodological limitations in the contributing studies, with the exception of moderate concerns in one study due to recruitment and data analysis; no concerns about the coherence of the finding with nothing to lower our confidence; no concerns about relevance; no concerns about inadequacy as the evidence is sufficiently deep (provide themes, with elaborations and examples). There was a judgement of moderate/ high confidence in this finding.</p></div><div id="niceng219er1.s1.1.6.1.7"><h5>Review finding 7: Role of GPs</h5><p>With consultation times being so short, it was difficult for many GPs to devote enough time to educating their patients about gout. GPs reported feeling insufficiently trained and lacking confidence in providing gout care and education. They reported that undergraduate and postgraduate training in the area had been poor and most of their knowledge was through self-directed learning. Often, GPs did not manage gout as a long-term condition, and prescribed medication only for acute attacks.</p><p>Most GPs questioned were not aware of existing guidelines relating to gout, but suggested flowcharts and websites would be helpful. In certain populations some GPs stated feeling uncomfortable with providing dietary advice due to cultural issues; and language barriers could also hinder the process of providing information.</p><p>Explanation of quality assessment: minor methodological limitations in two of the contributing studies and moderate concerns in two studies due to recruitment and data analysis; no concerns about the coherence of the finding with nothing to lower our confidence; no concerns about relevance; no concerns about inadequacy as the evidence is sufficiently deep (provide themes, with elaborations and examples). There was a judgement of moderate confidence in this finding.</p></div><div id="niceng219er1.s1.1.6.1.8"><h5>Review finding 8: Role of nurses</h5><p>Most nurses described having poor knowledge of gout, citing similar experiences to GPs with regards educational opportunities. They expressed a strong desire to learn more about the condition. Many nurses encounter patients with gout as a comorbidity in chronic disease management clinics, but felt they were well-placed to offer monitoring for patients on ULT and provide information to patients during monitoring.</p><p>Explanation of quality assessment: all studies had minor methodological limitations due to the unclear role of the researcher; no concerns about the coherence of the finding with nothing to lower our confidence; no concerns about relevance; no concerns about inadequacy as the evidence is sufficiently deep (provide themes, with elaborations and examples). There was a judgement of high confidence in this finding.</p></div><div id="niceng219er1.s1.1.6.1.9"><h5>Review finding 9: Role of pharmacists</h5><p>Pharmacists stated that they usually only provided information and advice at the first prescription but acknowledged that the nature of medication dispensing provided an opportunity for providing further advice and monitoring the condition. Some patients reported receiving information from the pharmacist</p><p>Explanation of quality assessment: moderate concerns in both studies due to recruitment and data analysis; no concerns about the coherence of the finding with nothing to lower our confidence; no concerns about relevance; no concerns about inadequacy as the evidence is sufficiently deep (provide themes, with elaborations and examples). There was a judgement of moderate confidence in this finding.</p></div><div id="niceng219er1.s1.1.6.1.10"><h5>Review finding 10: Specialist referral</h5><p>In some cases, patients asked for a referral to a rheumatologist as soon as they received a diagnosis, or prior to commencing allopurinol. Friends and family of patients with a history of gout would advise them to see a rheumatologist, in some cases instead of seeing a GP. In other cases, patients were unaware of the option of seeing a specialist.</p><p>Some GPs referred patients relatively frequently, to a rheumatologist or a dietician, others said it was not necessary when asked.</p></div></div><div id="niceng219er1.s1.1.6.2"><h5>Explanation of quality assessment</h5><p>All studies had minor methodological limitations due to the unclear role of the researcher; moderate concerns about the coherence of the finding with a variation in reported experiences; no concerns about relevance; no concerns about inadequacy as the evidence is sufficiently deep (provide themes, with elaborations and examples). There was a judgement of low confidence in this finding.</p><p>Qualitative evidence summary</p></div></div><div id="niceng219er1.s1.1.7"><h4>1.1.7. Economic evidence</h4><p>The committee agreed that health economic studies would not be relevant to this review question, and so were not sought.</p></div><div id="niceng219er1.s1.1.8"><h4>1.1.8. The committee’s discussion and interpretation of the evidence</h4><div id="niceng219er1.s1.1.8.1"><h5>1.1.8.1. The quality of the evidence</h5><p>Overall, the quality of the evidence was mostly graded by GRADE-CERQual as moderate/high confidence in the findings. An exception was for referral to a specialist which was graded low due to minor methodological limitations as well as a lack of coherence because of variation in experiences reported by patients requesting referral at first diagnosis. The committee thought that this was due to the varying expectations of people with gout but that referral to a rheumatologist is unlikely to be required at diagnosis. The rest of the evidence had only study limitations and no concerns about coherence, applicability or adequacy of the findings. The methodological limitations were mostly due to the unclear role of the researcher and sometimes due to the recruitment process or data analysis. This meant that overall, the committee had confidence in the findings and agreed they were reliable enough to make recommendations. However, they did think there was some limitation in the relevance of the role of GP, nurses and pharmacists as this included the education, they required to improve health practitioner knowledge. Although health professionals were included in the protocol this was regarding what information and support, they thought should be provided to the patient.</p></div><div id="niceng219er1.s1.1.8.2"><h5>1.1.8.2. Findings identified in the evidence synthesis</h5><p>One of the information needs identified in the review included the ‘causes of gout’, which were found to be often poorly understood by people with gout, their families, and health care professionals even when the patient had a family history of the condition. The prevailing belief was that gout was a self-inflicted disease brought on by dietary habits, rather than occurring as a result of genetics, obesity, comorbidities or medications. This was thought to make people resistant to seeking medical help. This belief linked to the second finding ‘dietary advice’. Many people requested dietary advice at their G.P. appointment to know what foods were advisable and which to avoid. The misconceptions about the effect diet had on the condition demonstrated the lack of knowledge of the pathophysiology of the disease and over emphasis placed on the role diet has in managing the condition. The evidence found people with gout thought that information available on dietary modifications was not always clear and sometimes contradicted the information provided by healthcare professionals. The committee agreed advice on diet was commonly asked for and acknowledged there was a lot of misleading information on diet available. The committee discussed the general lack of understanding of gout by patients and agreed provision of information on the causes of gout, and the signs and symptoms to look out for should be provided. The committee also discussed the importance of an awareness of risk factors when undertaking history taking and discussion of these with the person. Genetic links had been highlighted in the review, but the committee also raised obesity, comorbidities such as chronic kidney disease and hypertension, and polypharmacy were other risk factors that people should be informed about and included within the recommendation.</p><p>The theme around the ‘long-term impact of gout’ included the finding that more often GPs focused on acute flares and didn’t provide enough information about the long-term consequences of gout. This could contribute to poor adherence as patients may discontinue their medication earlier because they are unaware that gout is a chronic condition requiring long-term treatment. The evidence reported people discontinuing urate lowering therapy unaware that it is a preventative medication, but also that adherence improved when people were made aware of the long-term consequences of not continuing on ULT. Generally, people wanted more information on long-term medication. The committee agreed with the conclusions of this finding, and it reflected their own experience that there is a lack of understanding about gout being a condition requiring long-term treatment amongst health professionals as well as patients. They acknowledged there is often more focus by clinicians on treating a flare rather than managing the condition in the long-term, and patients will often look to altering diet or lifestyle as a means to improve their condition. The committee wanted to highlight that although a healthy diet and lifestyle should be promoted it will not stop the progression of gout without medication. The committee agreed people needed to be made aware that gout is a life-long condition requiring long-term medication in order to control urate levels, reduce flares and prevent permanent damage to joints.</p><p>The themes of ‘online sources of information’ and ‘information preferences’ were linked in that both highlighted conflicting, incorrect or ambiguous information being reported by gout patients. After receiving a diagnosis many people will seek further information via websites. The committee concurred with this and noted people should be signposted to reputable, trustworthy online sources such as NHS websites and recognised gout charities and organisations. People stated they wanted more time to discuss their condition particularly around the time of diagnosis. Generally, there was a preference for having written information that could be read in the person’s own time and shared with family or carers.</p><p>There were a few studies that looked at the requirement for ‘tailored information specifically for females. Often the possibility of women having gout was dismissed by health care professionals because of the belief it is not a condition that affects women, and this can lead to delays in diagnosis. Female patients wanted information tailored more towards them and their specific issues such as gout within younger age groups and links with menopause. The committee agreed that there was an embedded belief that gout was primarily only found in older males and that women could be mis-diagnosed because of this.</p><p>Generally, GPs and nurses reported that they lacked training in the condition and consequently believed they had insufficient knowledge to provide education and information to patients with any confidence. Nurses related their experience of caring for people with gout who have other chronic conditions and believed with the correct training they were well placed to monitor and provide information on medication such as ULT as part of monitoring a person’s other conditions. Pharmacists also stated they could bridge the gap between the GP and patient, providing advice on medication and directing people to other sources of information or back to their GP.</p><p>From the findings presented the committee decided to recommend providing tailored information as what was required would vary according to the needs of the individual and the stage of the care pathway they were on. They agreed it was important to highlight that this was best provided not only at the time of diagnosis but also at follow-up appointments, as the flare may not be the best time for patients to take in information when they are in acute pain. Providing information at subsequent appointments provides the opportunity to reinforce important messages and this allows the patient time to think about subsequent questions to ask to get the information they require. The committee reflected on the themes found within the evidence and used this as a basis to detail the key information that should be provided within the recommendation.</p></div><div id="niceng219er1.s1.1.8.3"><h5>1.1.8.3. Cost effectiveness and resource use</h5><p>Cost effectiveness evidence was not sought as this was a qualitative review. The recommendations made as a result of this review question provide guidance on what topics should be covered within a patient review. The committee agreed that this provision of information would not require an additional appointment and would likely be provided at the time of diagnosis or scheduled follow-up appointments. Therefore, this recommendation is not expected to result in a substantial resource impact.</p></div><div id="niceng219er1.s1.1.8.4"><h5>1.1.8.4. Other factors the committee took into account</h5><p>The committee noted that information on how to manage gout flares was not a theme that had emerged strongly from the evidence, however providing a person with information on the treatment options available was very important in order that the person can act quickly and bring their symptoms under control. Therefore, based on committee consensus this was included in the recommendation.</p><p>The committee agreed cross reference should be made to the recommendations within the NICE guidance Patient experience in adult NHS services and Shared decision making</p><p>The committee identified UK gout society as a useful online resource to use.</p></div></div><div id="niceng219er1.s1.1.9"><h4>1.1.9. Recommendations supported by this evidence review</h4><p>This evidence review supports recommendations 1.2.1 to 1.2.2.</p></div><div id="niceng219er1.rl.r1"><h4>1.1.10. References</h4><dl class="temp-labeled-list"><dt>1.</dt><dd><div class="bk_ref" id="niceng219er1.ref1">Aati
|
||
O, Taylor
|
||
WJ, Horne
|
||
A, Dalbeth
|
||
N. Toward development of a Tophus Impact Questionnaire: a qualitative study exploring the experience of people with tophaceous gout. JCR: Journal of Clinical Rheumatology. 2014; 20(5):251–255 [<a href="https://pubmed.ncbi.nlm.nih.gov/25036566" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 25036566</span></a>]</div></dd><dt>2.</dt><dd><div class="bk_ref" id="niceng219er1.ref2">Chandratre
|
||
P, Mallen
|
||
CD, Roddy
|
||
E, Liddle
|
||
J, Richardson
|
||
J. “You want to get on with the rest of your life": a qualitative study of health-related quality of life in gout. Clinical Rheumatology. 2016; 35(5):1197–1205 [<a href="/pmc/articles/PMC4844632/" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pmc">PMC free article<span class="bk_prnt">: PMC4844632</span></a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26245722" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 26245722</span></a>]</div></dd><dt>3.</dt><dd><div class="bk_ref" id="niceng219er1.ref3">Counsell
|
||
AB, Nguyen
|
||
AD, Baysari
|
||
MT, Kannangara
|
||
DR W, McLachlan
|
||
AJ, Day
|
||
RO. Exploring current and potential roles of Australian community pharmacists in gout management: a qualitative study. BMC Family Practice. 2018; 19(1):54 [<a href="/pmc/articles/PMC5941632/" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pmc">PMC free article<span class="bk_prnt">: PMC5941632</span></a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29743018" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 29743018</span></a>]</div></dd><dt>4.</dt><dd><div class="bk_ref" id="niceng219er1.ref4">Curiel
|
||
RV, Guzman
|
||
NJ. Challenges associated with the management of gouty arthritis in patients with chronic kidney disease: a systematic review. Seminars in Arthritis and Rheumatism. 2012; 42(2):166–178 [<a href="https://pubmed.ncbi.nlm.nih.gov/22560299" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 22560299</span></a>]</div></dd><dt>5.</dt><dd><div class="bk_ref" id="niceng219er1.ref5">Davatchi
|
||
F, Jamshidi
|
||
AR, Banihashemi
|
||
AT, Gholami
|
||
J, Forouzanfar
|
||
MH, Akhlaghi
|
||
M
|
||
et al
|
||
WHO-ILAR COPCORD Study (Stage 1, Urban Study) in Iran. Journal of Rheumatology. 2008; 35(7):1384 [<a href="https://pubmed.ncbi.nlm.nih.gov/18464299" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 18464299</span></a>]</div></dd><dt>6.</dt><dd><div class="bk_ref" id="niceng219er1.ref6">Day
|
||
RO, Frensham
|
||
LJ, Nguyen
|
||
AD, Baysari
|
||
MT, Aung
|
||
E, Lau
|
||
AY S
|
||
et al
|
||
Effectiveness of an electronic patient-centred self-management tool for gout sufferers: A cluster randomised controlled trail protocol. BMJ Open. 2017; 7(10):e017281 [<a href="/pmc/articles/PMC5652564/" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pmc">PMC free article<span class="bk_prnt">: PMC5652564</span></a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29042386" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 29042386</span></a>]</div></dd><dt>7.</dt><dd><div class="bk_ref" id="niceng219er1.ref7">Deprouw
|
||
C, Guignot
|
||
M, Bougeois-Sarran
|
||
C, Bougeois-Sarran
|
||
C, Coblentz-Baumann
|
||
L, Ea
|
||
HK. Partners and nurses’ knowledge and representations of gout: A qualitative study. Joint, Bone, Spine: Revue du Rhumatisme. 2019; 86(6):769–776 [<a href="https://pubmed.ncbi.nlm.nih.gov/31067503" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 31067503</span></a>]</div></dd><dt>8.</dt><dd><div class="bk_ref" id="niceng219er1.ref8">Dowell
|
||
A, Morris
|
||
C, Macdonald
|
||
L, Stubbe
|
||
M. “I can’t bend it and it hurts like mad”: direct observation of gout consultations in routine primary health care. BMC Family Practice. 2017; 18(1):91 [<a href="/pmc/articles/PMC5648494/" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pmc">PMC free article<span class="bk_prnt">: PMC5648494</span></a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29047331" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 29047331</span></a>]</div></dd><dt>9.</dt><dd><div class="bk_ref" id="niceng219er1.ref9">Fernon
|
||
A, Nguyen
|
||
A, Baysari
|
||
M, Day
|
||
R. A user-centred approach to designing an etool for gout management. Studies in Health Technology and Informatics. 2016; 227:28–33 Gout: Diagnosis and Management June 2022 [<a href="https://pubmed.ncbi.nlm.nih.gov/27440285" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 27440285</span></a>]</div></dd><dt>10.</dt><dd><div class="bk_ref" id="niceng219er1.ref10">Fields
|
||
TR, Batterman
|
||
A. How can we improve disease education in people with gout?
|
||
Current Rheumatology Reports. 2018; 20(3):12 [<a href="/pmc/articles/PMC5842278/" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pmc">PMC free article<span class="bk_prnt">: PMC5842278</span></a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29516200" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 29516200</span></a>]</div></dd><dt>11.</dt><dd><div class="bk_ref" id="niceng219er1.ref11">Fields
|
||
TR, Rifaat
|
||
A, Yee
|
||
AM F, Ashany
|
||
D, Kim
|
||
K, Tobin
|
||
M
|
||
et al
|
||
Pilot study of a multidisciplinary gout patient education and monitoring program. Seminars in Arthritis and Rheumatism. 2017; 46(5):601–608 [<a href="/pmc/articles/PMC5837038/" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pmc">PMC free article<span class="bk_prnt">: PMC5837038</span></a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27931979" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 27931979</span></a>]</div></dd><dt>12.</dt><dd><div class="bk_ref" id="niceng219er1.ref12">Gow
|
||
PJ, Gow
|
||
VF, Waldon
|
||
J. Societal and cultural attitudes to gout: An important consideration in the successful management of gout among maori in aotearoa New Zealand. Current Rheumatology Reviews. 2011; 7(2):170–180</div></dd><dt>13.</dt><dd><div class="bk_ref" id="niceng219er1.ref13">Harrold
|
||
LR, Mazor
|
||
KM, Velten
|
||
S, Ockene
|
||
IS, Yood
|
||
RA. Patients and providers view gout differently: a qualitative study. Chronic Illness. 2010; 6(4):263–271 [<a href="/pmc/articles/PMC3134238/" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pmc">PMC free article<span class="bk_prnt">: PMC3134238</span></a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20675361" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 20675361</span></a>]</div></dd><dt>14.</dt><dd><div class="bk_ref" id="niceng219er1.ref14">Hmar
|
||
RC, Kannangara
|
||
DR, Ramasamy
|
||
SN, Baysari
|
||
MT, Williams
|
||
KM, Day
|
||
RO. Understanding and improving the use of allopurinol in a teaching hospital. Internal Medicine Journal. 2015; 45(4):383–390 [<a href="https://pubmed.ncbi.nlm.nih.gov/25644128" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 25644128</span></a>]</div></dd><dt>15.</dt><dd><div class="bk_ref" id="niceng219er1.ref15">Howren
|
||
A, Cox
|
||
SM, Shojania
|
||
K, Rai
|
||
SK, Choi
|
||
HK, De Vera
|
||
MA. How patients with gout become engaged in disease management: a constructivist grounded theory study. Arthritis Research & Therapy. 2018; 20(1):110 [<a href="/pmc/articles/PMC5984761/" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pmc">PMC free article<span class="bk_prnt">: PMC5984761</span></a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29859127" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 29859127</span></a>]</div></dd><dt>16.</dt><dd><div class="bk_ref" id="niceng219er1.ref16">Humphrey
|
||
C, Hulme
|
||
R, Dalbeth
|
||
N, Gow
|
||
P, Arroll
|
||
B, Lindsay
|
||
K. A qualitative study to explore health professionals’ experience of treating gout: understanding perceived barriers to effective gout management. Journal of Primary Health Care. 2016; 8(2):149–156 [<a href="https://pubmed.ncbi.nlm.nih.gov/27477557" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 27477557</span></a>]</div></dd><dt>17.</dt><dd><div class="bk_ref" id="niceng219er1.ref17">Jeyaruban
|
||
A, Soden
|
||
M, Larkins
|
||
S. General practitioners’ perspectives on the management of gout: a qualitative study. Postgraduate Medical Journal. 2016; 92(1092):603–607 [<a href="https://pubmed.ncbi.nlm.nih.gov/27033862" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 27033862</span></a>]</div></dd><dt>18.</dt><dd><div class="bk_ref" id="niceng219er1.ref18">Jimenez-Linan
|
||
LM, Edwards
|
||
L, Abhishek
|
||
A, Doherty
|
||
M. Adequacy of online patient information resources on gout and potentially curative urate-lowering treatment. Arthritis Care and Research. 2017; 69(5):748–752 [<a href="https://pubmed.ncbi.nlm.nih.gov/27390083" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 27390083</span></a>]</div></dd><dt>19.</dt><dd><div class="bk_ref" id="niceng219er1.ref19">Jordan
|
||
KN, Pennebaker
|
||
JW, Petrie
|
||
KJ, Dalbeth
|
||
N. Googling gout: Exploring perceptions about gout through a linguistic analysis of online search activities. Arthritis Care and Research. 2019; 71(3):419–426 [<a href="https://pubmed.ncbi.nlm.nih.gov/29781577" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 29781577</span></a>]</div></dd><dt>20.</dt><dd><div class="bk_ref" id="niceng219er1.ref20">Katz
|
||
JL, Weiner
|
||
H, Yu
|
||
TF. Psychobiological variables in the onset and recurrence of gouty arthritis: a chronic disease model. Journal of Chronic Diseases. 1975; 28(1):51–62 [<a href="https://pubmed.ncbi.nlm.nih.gov/1110264" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 1110264</span></a>]</div></dd><dt>21.</dt><dd><div class="bk_ref" id="niceng219er1.ref21">Kelly
|
||
A, Tymms
|
||
K, de Wit
|
||
M, Bartlett
|
||
SJ, Cross
|
||
M, Dawson
|
||
T
|
||
et al
|
||
Patient and caregiver priorities for medication adherence in gout, osteoporosis and rheumatoid arthritis: nominal group technique. Arthritis Care and Research. 2020; 72(10):1410–1419 [<a href="https://pubmed.ncbi.nlm.nih.gov/31325214" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 31325214</span></a>]</div></dd><dt>22.</dt><dd><div class="bk_ref" id="niceng219er1.ref22">Kiadaliri
|
||
A, Moreno-Betancur
|
||
M, Turkiewicz
|
||
A, Englund
|
||
M. Educational inequalities in all-cause and cause-specific mortality among people with gout: a register-based matched cohort study in southern Sweden. International Journal for Equity in Health. 2019; 18(1):164 [<a href="/pmc/articles/PMC6819587/" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pmc">PMC free article<span class="bk_prnt">: PMC6819587</span></a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31660978" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 31660978</span></a>]</div></dd><dt>23.</dt><dd><div class="bk_ref" id="niceng219er1.ref23">Kool
|
||
EM, Nijsten
|
||
MJ, van Ede
|
||
AE, Jansen
|
||
TL, Taylor
|
||
WJ. Discrepancies in how the impact of gout is assessed in outcomes research compared to how health professionals view the impact of gout, using the lens of the International Classification of Functioning, Health and Disability (ICF). Clinical Rheumatology. 2016; 35(9):2259–2268 [<a href="https://pubmed.ncbi.nlm.nih.gov/27300705" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 27300705</span></a>]</div></dd><dt>24.</dt><dd><div class="bk_ref" id="niceng219er1.ref24">Krasnoryadtseva
|
||
A, Dalbeth
|
||
N, Petrie
|
||
K. Does seeing personal medical images change beliefs about illness and treatment in people with gout? A randomised controlled trial. Psychology & Health. 2020; 35(1): 107–123 [<a href="https://pubmed.ncbi.nlm.nih.gov/31184207" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 31184207</span></a>]</div></dd><dt>25.</dt><dd><div class="bk_ref" id="niceng219er1.ref25">Krasnoryadtseva
|
||
A, Dalbeth
|
||
N, Petrie
|
||
KJ. The effect of different styles of medical illustration on information comprehension, the perception of educational material and illness beliefs. Patient Education and Counseling. 2020; 103(3):556–562 [<a href="https://pubmed.ncbi.nlm.nih.gov/31601448" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 31601448</span></a>]</div></dd><dt>26.</dt><dd><div class="bk_ref" id="niceng219er1.ref26">Latif
|
||
ZP, Nakafero
|
||
G, Jenkins
|
||
W, Doherty
|
||
M, Abhishek
|
||
A. Implication of nurse intervention on engagement with urate-lowering drugs: A qualitative study of participants in a RCT of nurse led care. Joint, Bone, Spine: Revue du Rhumatisme. 2019; 86(3):357–362 [<a href="/pmc/articles/PMC6491495/" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pmc">PMC free article<span class="bk_prnt">: PMC6491495</span></a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30394337" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 30394337</span></a>]</div></dd><dt>27.</dt><dd><div class="bk_ref" id="niceng219er1.ref27">Liddle
|
||
J, Roddy
|
||
E, Mallen
|
||
CD, Hider
|
||
SL, Prinjha
|
||
S, Ziebland
|
||
S
|
||
et al
|
||
Mapping patients’ experiences from initial symptoms to gout diagnosis: a qualitative exploration. BMJ Open. 2015; 5(9):e008323 [<a href="/pmc/articles/PMC4577947/" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pmc">PMC free article<span class="bk_prnt">: PMC4577947</span></a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26369796" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 26369796</span></a>]</div></dd><dt>28.</dt><dd><div class="bk_ref" id="niceng219er1.ref28">Lindsay
|
||
K, Gow
|
||
P, Vanderpyl
|
||
J, Logo
|
||
P, Dalbeth
|
||
N. The experience and impact of living with gout: a study of men with chronic gout using a qualitative grounded theory approach. JCR: Journal of Clinical Rheumatology. 2011; 17(1): 1 –6 [<a href="https://pubmed.ncbi.nlm.nih.gov/21169857" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 21169857</span></a>]</div></dd><dt>29.</dt><dd><div class="bk_ref" id="niceng219er1.ref29">Martini
|
||
N, Bryant
|
||
L, Te Karu
|
||
L, Aho
|
||
L, Chan
|
||
R, Miao
|
||
J
|
||
et al
|
||
Living with gout in New Zealand: an exploratory study into people’s knowledge about the disease and its treatment. JCR: Journal of Clinical Rheumatology. 2012; 18(3): 125–129 [<a href="https://pubmed.ncbi.nlm.nih.gov/22426580" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 22426580</span></a>]</div></dd><dt>30.</dt><dd><div class="bk_ref" id="niceng219er1.ref30">Moghimi
|
||
N, Davatchi
|
||
F, Rahimi
|
||
E, Saidi
|
||
A, Rashadmanesh
|
||
N, Moghimi
|
||
S
|
||
et al
|
||
WHOILAR COPCORD study (stage 1, urban study) in Sanandaj, Iran. Clinical Rheumatology. 2015; 34(3):535–543 [<a href="https://pubmed.ncbi.nlm.nih.gov/24213781" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 24213781</span></a>]</div></dd><dt>31.</dt><dd><div class="bk_ref" id="niceng219er1.ref31">Morris
|
||
C, Macdonald
|
||
L, Stubbe
|
||
M, Dowell
|
||
A. “It’s complicated" - talking about gout medicines in primary care consultations: a qualitative study. BMC Family Practice. 2016; 17(1 ):114 [<a href="/pmc/articles/PMC4992199/" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pmc">PMC free article<span class="bk_prnt">: PMC4992199</span></a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27542754" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 27542754</span></a>]</div></dd><dt>32.</dt><dd><div class="bk_ref" id="niceng219er1.ref32">National Institute for Health and Care Excellence. Developing NICE guidelines: the manual [updated October 2020]. London. National Institute for Health and Care Excellence, 2014. Available from: <a href="http://www.nice.orq.uk/article/PMG20/chapter/1%20lntroduction%20and%20overview" ref="pagearea=cite-ref&targetsite=external&targetcat=link&targettype=uri">http://www<wbr style="display:inline-block"></wbr>.nice.orq.uk<wbr style="display:inline-block"></wbr>/article/PMG20/chapter<wbr style="display:inline-block"></wbr>/1%20lntroduction%20and%20overview</a></div></dd><dt>33.</dt><dd><div class="bk_ref" id="niceng219er1.ref33">Oh
|
||
H, Park
|
||
J, Seo
|
||
W. Development of a web-based gout self-management program. Orthopaedic Nursing. 2011; 30(5):333–341; quiz 342–333 [<a href="https://pubmed.ncbi.nlm.nih.gov/21934590" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 21934590</span></a>]</div></dd><dt>34.</dt><dd><div class="bk_ref" id="niceng219er1.ref34">Oh
|
||
HS, Park
|
||
W, Kwon
|
||
SR, Lim
|
||
MJ, Suh
|
||
YO, Seo
|
||
WS
|
||
et al
|
||
Effects of gout web based self-management program on knowledge related to disease, medication adherence, and self-management. Journal of korean academy of nursing. 2013; 43(4):547–556 [<a href="https://pubmed.ncbi.nlm.nih.gov/24071759" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 24071759</span></a>]</div></dd><dt>35.</dt><dd><div class="bk_ref" id="niceng219er1.ref35">Petrie
|
||
KJ, MacKrill
|
||
K, Derksen
|
||
C, Dalbeth
|
||
N. An illness by any other name: The effect of renaming gout on illness and treatment perceptions. Health Psychology. 2018; 37(1):37–41 ” [<a href="https://pubmed.ncbi.nlm.nih.gov/28836797" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 28836797</span></a>]</div></dd><dt>36.</dt><dd><div class="bk_ref" id="niceng219er1.ref36">Punzi
|
||
L, Medea
|
||
G. Understanding and perceptions of gout: An interdisciplinary assessment among patients, physicians and pharmacists in Italy. Reumatismo. 2020; 72(1):31–43 [<a href="https://pubmed.ncbi.nlm.nih.gov/32292019" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 32292019</span></a>]</div></dd><dt>37.</dt><dd><div class="bk_ref" id="niceng219er1.ref37">Rai
|
||
SK, Choi
|
||
HK, Choi
|
||
SH J, Townsend
|
||
AF, Shojania
|
||
K, De Vera
|
||
MA. Key barriers to gout care: a systematic review and thematic synthesis of qualitative studies. Rheumatology. 2018; 57(7):1282–1292 [<a href="/pmc/articles/PMC6014336/" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pmc">PMC free article<span class="bk_prnt">: PMC6014336</span></a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29672772" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 29672772</span></a>]</div></dd><dt>38.</dt><dd><div class="bk_ref" id="niceng219er1.ref38">Rakic
|
||
M, Wienand
|
||
I, Shaw
|
||
D, Nast
|
||
R, Eiger
|
||
BS. Autonomy and fear of synthetic biology: How can patients’ autonomy be enhanced in the field of synthetic biology? A qualitative study with stable patients. Science & Engineering Ethics. 2017; 23(2):375–388 [<a href="https://pubmed.ncbi.nlm.nih.gov/27138379" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 27138379</span></a>]</div></dd><dt>39.</dt><dd><div class="bk_ref" id="niceng219er1.ref39">Ramsubeik
|
||
K, Ramrattan
|
||
LA, Kaeley
|
||
GS, Singh
|
||
JA. Effectiveness of healthcare educational and behavioral interventions to improve gout outcomes: a systematic review and meta-analysis. Therapeutic Advances in Musculoskeletal Disease. 2018; 10(12):235–252 [<a href="/pmc/articles/PMC6262501/" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pmc">PMC free article<span class="bk_prnt">: PMC6262501</span></a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30515250" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 30515250</span></a>]</div></dd><dt>40.</dt><dd><div class="bk_ref" id="niceng219er1.ref40">Rebello
|
||
C, Thomson
|
||
M, Bassett-Clarke
|
||
D, Martini
|
||
N. Patient awareness, knowledge and use of colchicine: an exploratory qualitative study in the Counties Manukau region, Auckland, New Zealand. Journal of Primary Health Care. 2016; 8(2):140–148 [<a href="https://pubmed.ncbi.nlm.nih.gov/27477556" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 27477556</span></a>]</div></dd><dt>41.</dt><dd><div class="bk_ref" id="niceng219er1.ref41">Richardson
|
||
JC, Liddle
|
||
J, Mallen
|
||
CD, Roddy
|
||
E, Hider
|
||
S, Prinjha
|
||
S
|
||
et al
|
||
A joint effort over a period of time: factors affecting use of urate-lowering therapy for long-term treatment of gout. BMC Musculoskeletal Disorders. 2016; 17:249 [<a href="/pmc/articles/PMC4895958/" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pmc">PMC free article<span class="bk_prnt">: PMC4895958</span></a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27267878" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 27267878</span></a>]</div></dd><dt>42.</dt><dd><div class="bk_ref" id="niceng219er1.ref42">Richardson
|
||
JC, Liddle
|
||
J, Mallen
|
||
CD, Roddy
|
||
E, Prinjha
|
||
S, Ziebland
|
||
S
|
||
et al
|
||
“Why me? I don’t fit the mould ... I am a freak of nature": a qualitative study of women’s experience of gout. BMC Women’s Health. 2015; 15:122 [<a href="/pmc/articles/PMC4693432/" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pmc">PMC free article<span class="bk_prnt">: PMC4693432</span></a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26710971" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 26710971</span></a>]</div></dd><dt>43.</dt><dd><div class="bk_ref" id="niceng219er1.ref43">Rogers
|
||
A, Flynn
|
||
RW V, Mackenzie
|
||
IS, MacDonald
|
||
TM. Does the provision of a DVD-based audio-visual presentation improve recruitment in a clinical trial? A randomised trial of DVD trial invitations. BMC Medical Research Methodology. 2019; 19(1):24 [<a href="/pmc/articles/PMC6354366/" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pmc">PMC free article<span class="bk_prnt">: PMC6354366</span></a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30700250" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 30700250</span></a>]</div></dd><dt>44.</dt><dd><div class="bk_ref" id="niceng219er1.ref44">Rolland T-
|
||
MC, Lawn
|
||
R. Owning my gout - engaging people with gout in a pharmacistled collaborative gout management service. International Journal of Integrated Care (IJIC). 2017; 17(3):200–201</div></dd><dt>45.</dt><dd><div class="bk_ref" id="niceng219er1.ref45">Schroter
|
||
S, Pakpoor
|
||
J, Morris
|
||
J, Chew
|
||
M, Godlee
|
||
F. Effect of different financial competing interest statements on readers’ perceptions of clinical educational articles: a randomised controlled trial. BMJ Open. 2019; 9(2):e025029 [<a href="/pmc/articles/PMC6377520/" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pmc">PMC free article<span class="bk_prnt">: PMC6377520</span></a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30782923" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 30782923</span></a>]</div></dd><dt>46.</dt><dd><div class="bk_ref" id="niceng219er1.ref46">Seow
|
||
LL, Jiao
|
||
N, Wang
|
||
W, Holroyd
|
||
E, Teng
|
||
GG, He
|
||
HG. A qualitative study exploring perceptions of patients with gout. Clinical Nursing Research. 2020; 29(1):56–65 [<a href="https://pubmed.ncbi.nlm.nih.gov/29631416" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 29631416</span></a>]</div></dd><dt>47.</dt><dd><div class="bk_ref" id="niceng219er1.ref47">Singh
|
||
JA. Challenges faced by patients in gout treatment: a qualitative study. JCR: Journal of Clinical Rheumatology. 2014; 20(3):172–174 [<a href="/pmc/articles/PMC4169366/" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pmc">PMC free article<span class="bk_prnt">: PMC4169366</span></a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24662562" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 24662562</span></a>]</div></dd><dt>48.</dt><dd><div class="bk_ref" id="niceng219er1.ref48">Singh
|
||
JA. Facilitators and barriers to adherence to urate-lowering therapy in African-Americans with gout: a qualitative study. Arthritis Research & Therapy. 2014; 16(2):R82 [<a href="/pmc/articles/PMC4060486/" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pmc">PMC free article<span class="bk_prnt">: PMC4060486</span></a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24678765" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 24678765</span></a>]</div></dd><dt>49.</dt><dd><div class="bk_ref" id="niceng219er1.ref49">Singh
|
||
JA. The impact of gout on patient’s lives: A study of African-American and Caucasian men and women with gout. Arthritis Research and Therapy. 2014; 16:R132 [<a href="/pmc/articles/PMC4230273/" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pmc">PMC free article<span class="bk_prnt">: PMC4230273</span></a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24961941" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 24961941</span></a>]</div></dd><dt>50.</dt><dd><div class="bk_ref" id="niceng219er1.ref50">Singh
|
||
JA. Patient perspectives in gout: a review. Current Opinion in Rheumatology. 2019; 31(2):159–166 [<a href="https://pubmed.ncbi.nlm.nih.gov/30575598" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 30575598</span></a>]</div></dd><dt>51.</dt><dd><div class="bk_ref" id="niceng219er1.ref51">Singh
|
||
JA, Edwards
|
||
NL. Patient Perceptions of Gout Management Goals: A Cross-sectional Internet Survey. Journal of Clinical Rheumatology. 2020; 26(4):129–133 [<a href="https://pubmed.ncbi.nlm.nih.gov/32453285" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 32453285</span></a>]</div></dd><dt>52.</dt><dd><div class="bk_ref" id="niceng219er1.ref52">Spaetgens
|
||
B, Pustjens
|
||
T, Scheepers
|
||
L, Janssens
|
||
H, van der Linden
|
||
S, Boonen
|
||
A. Knowledge, illness perceptions and stated clinical practice behaviour in management of gout: a mixed methods study in general practice. Clinical Rheumatology. 2016; 35(8):2053–2061 [<a href="/pmc/articles/PMC4960270/" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pmc">PMC free article<span class="bk_prnt">: PMC4960270</span></a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26898982" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 26898982</span></a>]</div></dd><dt>53.</dt><dd><div class="bk_ref" id="niceng219er1.ref53">Spencer
|
||
K, Carr
|
||
A, Doherty
|
||
M. Patient and provider barriers to effective management of gout in general practice: a qualitative study. Annals of the Rheumatic Diseases. 2012; 71(9):1490–1495 [<a href="https://pubmed.ncbi.nlm.nih.gov/22440822" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 22440822</span></a>]</div></dd><dt>54.</dt><dd><div class="bk_ref" id="niceng219er1.ref54">Stewart
|
||
S, Dalbeth
|
||
N, Vandal
|
||
AC, Rome
|
||
K. The first metatarsophalangeal joint in gout: a systematic review and meta-analysis. BMC Musculoskeletal Disorders. 2016; 17:69 [<a href="/pmc/articles/PMC4750194/" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pmc">PMC free article<span class="bk_prnt">: PMC4750194</span></a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26864742" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 26864742</span></a>]</div></dd><dt>55.</dt><dd><div class="bk_ref" id="niceng219er1.ref55">Stewart
|
||
S, Guillen
|
||
AG, Taylor
|
||
WJ, Gaffo
|
||
A, Slark
|
||
J, Gott
|
||
M
|
||
et al
|
||
The experience of a gout flare: a meta-synthesis of qualitative studies. Seminars in Arthritis and Rheumatism. 2020; 50(4):805–811 [<a href="https://pubmed.ncbi.nlm.nih.gov/32554059" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 32554059</span></a>]</div></dd><dt>56.</dt><dd><div class="bk_ref" id="niceng219er1.ref56">Te Karu
|
||
L, Bryant
|
||
L, Elley
|
||
CR. Maori experiences and perceptions of gout and its treatment: a kaupapa Maori qualitative study. Journal of Primary Health Care. 2013; 5(3):214–222 [<a href="https://pubmed.ncbi.nlm.nih.gov/23998172" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 23998172</span></a>]</div></dd><dt>57.</dt><dd><div class="bk_ref" id="niceng219er1.ref57">Teoh
|
||
N, Gamble
|
||
GD, Horne
|
||
A, Taylor
|
||
WJ, Palmano
|
||
K, Dalbeth
|
||
N. The challenges of gout flare reporting: mapping flares during a randomized controlled trial. Bmc Rheumatology. 2019; 3:27 [<a href="/pmc/articles/PMC6615178/" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pmc">PMC free article<span class="bk_prnt">: PMC6615178</span></a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31334482" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 31334482</span></a>]</div></dd><dt>58.</dt><dd><div class="bk_ref" id="niceng219er1.ref58">Vaccher
|
||
S, Kannangara
|
||
DR, Baysari
|
||
MT, Reath
|
||
J, Zwar
|
||
N, Williams
|
||
KM
|
||
et al
|
||
Barriers to care in gout: From prescriber to patient. Journal of Rheumatology. 2016; 43(1):144–149 [<a href="https://pubmed.ncbi.nlm.nih.gov/26568590" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 26568590</span></a>]</div></dd><dt>59.</dt><dd><div class="bk_ref" id="niceng219er1.ref59">van Onna
|
||
M, Hinsenveld
|
||
E, de Vries
|
||
H, Boonen
|
||
A. Health literacy in patients dealing with gout: a qualitative study. Clinical Rheumatology. 2015; 34(9):1599–1603 [<a href="https://pubmed.ncbi.nlm.nih.gov/25501463" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 25501463</span></a>]</div></dd><dt>60.</dt><dd><div class="bk_ref" id="niceng219er1.ref60">Zhang
|
||
Y, Chaisson
|
||
CE, McAlindon
|
||
T, Woods
|
||
R, Hunter
|
||
DJ, Niu
|
||
J
|
||
et al
|
||
The online case-crossover study is a novel approach to study triggers for recurrent disease flares. Journal of Clinical Epidemiology. 2007; 60(1):50–55 [<a href="https://pubmed.ncbi.nlm.nih.gov/17161754" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 17161754</span></a>]</div></dd></dl></div></div></div><div id="appendixesappgroup1"><h2 id="_appendixesappgroup1_">Appendices</h2><div id="niceng219er1.appa"><h3>Appendix A. Review protocols</h3><p id="niceng219er1.appa.et1"><a href="/books/NBK589578/bin/niceng219er1-appa-et1.pdf" class="bk_dwnld_icn bk_dwnld_pdf">Review protocol for patient information</a><span class="small"> (PDF, 168K)</span></p></div><div id="niceng219er1.appb"><h3>Appendix B. Literature search strategies</h3><ul><li class="half_rhythm"><div>What information and support is needed by people with gout and their families or carers in relation to gout, and when should this be provided?</div></li></ul><p>The literature searches for this review are detailed below and complied with the methodology outlined in Developing NICE guidelines: the manual.<a class="bk_pop" href="#niceng219er1.ref32"><sup>32</sup></a></p><p>For more information, please see the Methodology review published as part of the accompanying documents for this guideline.</p><p id="niceng219er1.appb.et1"><a href="/books/NBK589578/bin/niceng219er1-appb-et1.pdf" class="bk_dwnld_icn bk_dwnld_pdf">B.1. Clinical search literature search strategy</a><span class="small"> (PDF, 184K)</span></p></div><div id="niceng219er1.appc"><h3>Appendix C. Qualitative evidence study selection</h3><p id="niceng219er1.appc.et1"><a href="/books/NBK589578/bin/niceng219er1-appc-et1.pdf" class="bk_dwnld_icn bk_dwnld_pdf">Download PDF</a><span class="small"> (103K)</span></p></div><div id="niceng219er1.appd"><h3>Appendix D. Qualitative evidence</h3><p id="niceng219er1.appd.et1"><a href="/books/NBK589578/bin/niceng219er1-appd-et1.pdf" class="bk_dwnld_icn bk_dwnld_pdf">Download PDF</a><span class="small"> (391K)</span></p></div><div id="niceng219er1.appe"><h3>Appendix E. GRADE-CERQual tables</h3><p id="niceng219er1.appe.et1"><a href="/books/NBK589578/bin/niceng219er1-appe-et1.pdf" class="bk_dwnld_icn bk_dwnld_pdf">Download PDF</a><span class="small"> (163K)</span></p></div><div id="niceng219er1.appf"><h3>Appendix F. Excluded studies</h3><div id="niceng219er1.appf.s1"><h4>Clinical studies</h4><div id="niceng219er1.appf.tab1" class="table"><h3><span class="label">Table 6</span><span class="title">Studies excluded from the qualitative review</span></h3><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK589578/table/niceng219er1.appf.tab1/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__niceng219er1.appf.tab1_lrgtbl__"><table><thead><tr><th id="hd_h_niceng219er1.appf.tab1_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;"></th><th id="hd_h_niceng219er1.appf.tab1_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Reason for exclusion</th></tr></thead><tbody><tr><td headers="hd_h_niceng219er1.appf.tab1_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Aati, 2014<a class="bk_pop" href="#niceng219er1.ref1"><sup>1</sup></a></td><td headers="hd_h_niceng219er1.appf.tab1_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">No relevant outcomes</td></tr><tr><td headers="hd_h_niceng219er1.appf.tab1_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Curiel, 2012<a class="bk_pop" href="#niceng219er1.ref4"><sup>4</sup></a></td><td headers="hd_h_niceng219er1.appf.tab1_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Incorrect study design: systematic review of drugs for people with gout and CKD</td></tr><tr><td headers="hd_h_niceng219er1.appf.tab1_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Davatchi, 2008<a class="bk_pop" href="#niceng219er1.ref5"><sup>5</sup></a></td><td headers="hd_h_niceng219er1.appf.tab1_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Incorrect study design: Epidemiological study; quantitative interviews with the general population to assess prevalence of different musculoskeletal complaints</td></tr><tr><td headers="hd_h_niceng219er1.appf.tab1_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Day, 2017<a class="bk_pop" href="#niceng219er1.ref6"><sup>6</sup></a></td><td headers="hd_h_niceng219er1.appf.tab1_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Incorrect study design: RCT protocol</td></tr><tr><td headers="hd_h_niceng219er1.appf.tab1_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Dowell, 2017<a class="bk_pop" href="#niceng219er1.ref8"><sup>8</sup></a></td><td headers="hd_h_niceng219er1.appf.tab1_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Does not match review question (secondary analysis of a paper looking at gout consultations)</td></tr><tr><td headers="hd_h_niceng219er1.appf.tab1_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Fernon, 2016<a class="bk_pop" href="#niceng219er1.ref9"><sup>9</sup></a></td><td headers="hd_h_niceng219er1.appf.tab1_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Does not match review question (patients’ views on design of an e-tool for gout management)</td></tr><tr><td headers="hd_h_niceng219er1.appf.tab1_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Fields, 2017<a class="bk_pop" href="#niceng219er1.ref11"><sup>11</sup></a></td><td headers="hd_h_niceng219er1.appf.tab1_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Incorrect study design: not qualitative- evaluating MDT educational programme (quantitative data only)</td></tr><tr><td headers="hd_h_niceng219er1.appf.tab1_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Fields, 2018<a class="bk_pop" href="#niceng219er1.ref10"><sup>10</sup></a></td><td headers="hd_h_niceng219er1.appf.tab1_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Incorrect study design: review paper</td></tr><tr><td headers="hd_h_niceng219er1.appf.tab1_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Gow, 2011<a class="bk_pop" href="#niceng219er1.ref12"><sup>12</sup></a></td><td headers="hd_h_niceng219er1.appf.tab1_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Not available</td></tr><tr><td headers="hd_h_niceng219er1.appf.tab1_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Hmar, 2015<a class="bk_pop" href="#niceng219er1.ref14"><sup>14</sup></a></td><td headers="hd_h_niceng219er1.appf.tab1_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">No relevant outcomes</td></tr><tr><td headers="hd_h_niceng219er1.appf.tab1_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Jimenez-Linan, 2017<a class="bk_pop" href="#niceng219er1.ref18"><sup>18</sup></a></td><td headers="hd_h_niceng219er1.appf.tab1_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Incorrect study design: survey of online patient information resources; accuracy assessed by rheumatology fellows</td></tr><tr><td headers="hd_h_niceng219er1.appf.tab1_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Jordan, 2019<a class="bk_pop" href="#niceng219er1.ref19"><sup>19</sup></a></td><td headers="hd_h_niceng219er1.appf.tab1_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Incorrect study design: Linguistic analysis of search histories of people searching for gout; no qualitative data analysis (themes)</td></tr><tr><td headers="hd_h_niceng219er1.appf.tab1_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Katz, 1975<a class="bk_pop" href="#niceng219er1.ref20"><sup>20</sup></a></td><td headers="hd_h_niceng219er1.appf.tab1_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">No relevant outcomes</td></tr><tr><td headers="hd_h_niceng219er1.appf.tab1_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Kelly, 2020<a class="bk_pop" href="#niceng219er1.ref21"><sup>21</sup></a></td><td headers="hd_h_niceng219er1.appf.tab1_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Incorrect population (included other forms of arthritis; very limited themes specific to gout)</td></tr><tr><td headers="hd_h_niceng219er1.appf.tab1_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Kiadaliri, 2019<a class="bk_pop" href="#niceng219er1.ref22"><sup>22</sup></a></td><td headers="hd_h_niceng219er1.appf.tab1_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Incorrect study design: Matched cohort study assessing relationship between educational inequalities and mortality in people with gout</td></tr><tr><td headers="hd_h_niceng219er1.appf.tab1_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Kool, 2016<a class="bk_pop" href="#niceng219er1.ref23"><sup>23</sup></a></td><td headers="hd_h_niceng219er1.appf.tab1_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Incorrect study design: Delphi conducted among health professionals and systematic review to identify potential items of a gout specific ICF core set</td></tr><tr><td headers="hd_h_niceng219er1.appf.tab1_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Krasnoryadtseva, 2020<a class="bk_pop" href="#niceng219er1.ref24"><sup>24</sup></a></td><td headers="hd_h_niceng219er1.appf.tab1_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Incorrect study design: RCT comparing education interventions including personal versus generic medical images</td></tr><tr><td headers="hd_h_niceng219er1.appf.tab1_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Krasnoryadtseva, 2020<a class="bk_pop" href="#niceng219er1.ref25"><sup>25</sup></a></td><td headers="hd_h_niceng219er1.appf.tab1_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Incorrect study design: the general public completed a quantitative questionnaire about an information leaflet on gout.</td></tr><tr><td headers="hd_h_niceng219er1.appf.tab1_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Moghimi, 2015<a class="bk_pop" href="#niceng219er1.ref30"><sup>30</sup></a></td><td headers="hd_h_niceng219er1.appf.tab1_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Incorrect study design: Epidemiological study; quantitative interviews with the general population to assess prevalence of different musculoskeletal complaints</td></tr><tr><td headers="hd_h_niceng219er1.appf.tab1_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Morris, 2016<a class="bk_pop" href="#niceng219er1.ref31"><sup>31</sup></a></td><td headers="hd_h_niceng219er1.appf.tab1_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Incorrect study design (analysis of consultations- not interviews)</td></tr><tr><td headers="hd_h_niceng219er1.appf.tab1_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Oh, 2011<a class="bk_pop" href="#niceng219er1.ref33"><sup>33</sup></a></td><td headers="hd_h_niceng219er1.appf.tab1_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Incorrect study design: Patient interviews and literature review to evaluate a web-based self-management program; states that interview questions were open and close ended but all results are in percentages.</td></tr><tr><td headers="hd_h_niceng219er1.appf.tab1_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Oh, 2013<a class="bk_pop" href="#niceng219er1.ref34"><sup>34</sup></a></td><td headers="hd_h_niceng219er1.appf.tab1_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Not English language</td></tr><tr><td headers="hd_h_niceng219er1.appf.tab1_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Petrie, 2018<a class="bk_pop" href="#niceng219er1.ref35"><sup>35</sup></a></td><td headers="hd_h_niceng219er1.appf.tab1_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Incorrect study design and population: quantitative questionnaires used to assess effect of renaming gout of illness perception among general public.</td></tr><tr><td headers="hd_h_niceng219er1.appf.tab1_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Punzi, 2020<a class="bk_pop" href="#niceng219er1.ref36"><sup>36</sup></a></td><td headers="hd_h_niceng219er1.appf.tab1_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Incorrect study design (survey- quantitative data only)</td></tr><tr><td headers="hd_h_niceng219er1.appf.tab1_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Rai, 2018<a class="bk_pop" href="#niceng219er1.ref37"><sup>37</sup></a></td><td headers="hd_h_niceng219er1.appf.tab1_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Incorrect study design: systematic review which does not directly answer question and has no quality assessment.</td></tr><tr><td headers="hd_h_niceng219er1.appf.tab1_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Rakic, 2017<a class="bk_pop" href="#niceng219er1.ref38"><sup>38</sup></a></td><td headers="hd_h_niceng219er1.appf.tab1_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Incorrect study population: interviews about synthetic biology with people with gout and diabetes and unclear what proportion had gout</td></tr><tr><td headers="hd_h_niceng219er1.appf.tab1_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Ramsubeik, 2018<a class="bk_pop" href="#niceng219er1.ref39"><sup>39</sup></a></td><td headers="hd_h_niceng219er1.appf.tab1_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Incorrect study design: Systematic review of RCTs and observational studies of educational and behavioural interventions</td></tr><tr><td headers="hd_h_niceng219er1.appf.tab1_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Rogers, 2019<a class="bk_pop" href="#niceng219er1.ref43"><sup>43</sup></a></td><td headers="hd_h_niceng219er1.appf.tab1_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Incorrect study design: RCT comparing effect of different study invitation materials on trial participation</td></tr><tr><td headers="hd_h_niceng219er1.appf.tab1_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Rolland, 2017<a class="bk_pop" href="#niceng219er1.ref44"><sup>44</sup></a></td><td headers="hd_h_niceng219er1.appf.tab1_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Incorrect study design: abstract only</td></tr><tr><td headers="hd_h_niceng219er1.appf.tab1_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Schroter, 2019<a class="bk_pop" href="#niceng219er1.ref45"><sup>45</sup></a></td><td headers="hd_h_niceng219er1.appf.tab1_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Incorrect study design: RCT comparing effect of different competing interest statements on doctors’ perceptions of education articles</td></tr><tr><td headers="hd_h_niceng219er1.appf.tab1_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Singh, 2014<a class="bk_pop" href="#niceng219er1.ref48"><sup>48</sup></a></td><td headers="hd_h_niceng219er1.appf.tab1_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">No relevant outcomes</td></tr><tr><td headers="hd_h_niceng219er1.appf.tab1_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Singh, 2014<a class="bk_pop" href="#niceng219er1.ref47"><sup>47</sup></a></td><td headers="hd_h_niceng219er1.appf.tab1_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">No relevant outcomes</td></tr><tr><td headers="hd_h_niceng219er1.appf.tab1_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Singh, 2014<a class="bk_pop" href="#niceng219er1.ref49"><sup>49</sup></a></td><td headers="hd_h_niceng219er1.appf.tab1_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">No relevant outcomes</td></tr><tr><td headers="hd_h_niceng219er1.appf.tab1_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Singh, 2019<a class="bk_pop" href="#niceng219er1.ref50"><sup>50</sup></a></td><td headers="hd_h_niceng219er1.appf.tab1_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Incorrect study design: literature review</td></tr><tr><td headers="hd_h_niceng219er1.appf.tab1_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Singh, 2020<a class="bk_pop" href="#niceng219er1.ref51"><sup>51</sup></a></td><td headers="hd_h_niceng219er1.appf.tab1_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Incorrect study design: internet survey- form with a list of responses to areas for improvement</td></tr><tr><td headers="hd_h_niceng219er1.appf.tab1_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Spaetgens, 2016<a class="bk_pop" href="#niceng219er1.ref52"><sup>52</sup></a></td><td headers="hd_h_niceng219er1.appf.tab1_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">No relevant outcomes</td></tr><tr><td headers="hd_h_niceng219er1.appf.tab1_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Spencer, 2012<a class="bk_pop" href="#niceng219er1.ref53"><sup>53</sup></a></td><td headers="hd_h_niceng219er1.appf.tab1_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Incorrect study design: systematic review which is not relevant to outcomes of interest.</td></tr><tr><td headers="hd_h_niceng219er1.appf.tab1_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Stewart, 2016<a class="bk_pop" href="#niceng219er1.ref54"><sup>54</sup></a></td><td headers="hd_h_niceng219er1.appf.tab1_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Incorrect study design: Systematic review of RCTs and observational studies of the first metatarsophalangeal joint</td></tr><tr><td headers="hd_h_niceng219er1.appf.tab1_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Stewart, 2020<a class="bk_pop" href="#niceng219er1.ref55"><sup>55</sup></a></td><td headers="hd_h_niceng219er1.appf.tab1_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">No relevant outcomes</td></tr><tr><td headers="hd_h_niceng219er1.appf.tab1_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Teoh, 2019<a class="bk_pop" href="#niceng219er1.ref57"><sup>57</sup></a></td><td headers="hd_h_niceng219er1.appf.tab1_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Incorrect study design: flare diary entries were analysed; no qualitative data</td></tr><tr><td headers="hd_h_niceng219er1.appf.tab1_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Zhang, 2007<a class="bk_pop" href="#niceng219er1.ref60"><sup>60</sup></a></td><td headers="hd_h_niceng219er1.appf.tab1_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Incorrect study design: Quantitative questionnaires used to assess risk factors for recurrent gout attacks.</td></tr></tbody></table></div></div><div id="niceng219er1.appf.tab2" class="table"><h3><span class="label">Table 7</span><span class="title">Studies identified but not included in the qualitative review due to saturation being reached</span></h3><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK589578/table/niceng219er1.appf.tab2/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__niceng219er1.appf.tab2_lrgtbl__"><table><thead><tr><th id="hd_h_niceng219er1.appf.tab2_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Study</th><th id="hd_h_niceng219er1.appf.tab2_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Reason</th></tr></thead><tbody><tr><td headers="hd_h_niceng219er1.appf.tab2_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Lindsay, 2011<a class="bk_pop" href="#niceng219er1.ref28"><sup>28</sup></a></td><td headers="hd_h_niceng219er1.appf.tab2_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">No relevant themes apart from a single quote adding to the theme of l for long-term impact of gout. The theme had already reached saturation point (where 8 studies were already included) so this study was excluded</td></tr></tbody></table></div></div></div></div></div><div class="bk_prnt_sctn"><h2>Tables</h2><div class="whole_rhythm bk_prnt_obj bk_first_prnt_obj"><div id="niceng219er1.tab1" class="table"><h3><span class="label">Table 1</span><span class="title">PICO characteristics of review question</span></h3><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK589578/table/niceng219er1.tab1/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__niceng219er1.tab1_lrgtbl__"><table><tbody><tr><th id="hd_b_niceng219er1.tab1_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Objective</th><td headers="hd_b_niceng219er1.tab1_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
|
||
<ul><li class="half_rhythm"><div>To determine what information and support should be provided to people with gout and their families or carer, for example: Methods of diagnosis</div></li><li class="half_rhythm"><div>Long-term impact of gout</div></li><li class="half_rhythm"><div>Treatment options</div></li><li class="half_rhythm"><div>Timing</div></li><li class="half_rhythm"><div>Causes of gout (risk factors)</div></li><li class="half_rhythm"><div>Pathophysiology (hyperuricemia, crystal deposition disease)</div></li></ul>
|
||
</td></tr><tr><th id="hd_b_niceng219er1.tab1_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Population and setting</th><td headers="hd_b_niceng219er1.tab1_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
|
||
<p>Inclusion: Adults (18 years and older) with gout and their families or carers, and health care professionals.</p>
|
||
<p>Opinions of adults with gout and their families or carers, and health professionals.</p>
|
||
<p>Exclusion: People with calcium pyrophosphate crystal deposition, including pseudogout.</p>
|
||
</td></tr><tr><th id="hd_b_niceng219er1.tab1_1_1_3_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Context</th><td headers="hd_b_niceng219er1.tab1_1_1_3_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">The context will depend on what is found within the studies.</td></tr><tr><th id="hd_b_niceng219er1.tab1_1_1_4_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Review strategy</th><td headers="hd_b_niceng219er1.tab1_1_1_4_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Synthesis of qualitative research. Results presented in narrative and table format. Quality of the evidence will be assessed by a GRADE CerQual approach for each review finding.</td></tr></tbody></table></div></div></div><div class="whole_rhythm bk_prnt_obj"><div id="niceng219er1.tab2" class="table"><h3><span class="label">Table 2</span><span class="title">Summary of studies included in the evidence review</span></h3><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK589578/table/niceng219er1.tab2/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__niceng219er1.tab2_lrgtbl__"><table><thead><tr><th id="hd_h_niceng219er1.tab2_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Study</th><th id="hd_h_niceng219er1.tab2_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Design</th><th id="hd_h_niceng219er1.tab2_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Population</th><th id="hd_h_niceng219er1.tab2_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Research aim</th><th id="hd_h_niceng219er1.tab2_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Comments</th></tr></thead><tbody><tr><td headers="hd_h_niceng219er1.tab2_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Chandratre 2016<a class="bk_pop" href="#niceng219er1.ref2"><sup>2</sup></a></td><td headers="hd_h_niceng219er1.tab2_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Focus groups with thematic analysis</td><td headers="hd_h_niceng219er1.tab2_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
|
||
<p>Patients from the baseline phase of a cohort study of HRQOL in gout. n= 17; 15 M/2F; mean age 71 years</p>
|
||
<p>UK</p>
|
||
</td><td headers="hd_h_niceng219er1.tab2_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">To examine the impact of gout and its treatments on health-related quality of life using focus group interviews.</td><td headers="hd_h_niceng219er1.tab2_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
|
||
<p>Exclusively Caucasian and mainly male.</p>
|
||
<p>Study was focused on HRQOL in gout.</p>
|
||
</td></tr><tr><td headers="hd_h_niceng219er1.tab2_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Counsell, 2018<a class="bk_pop" href="#niceng219er1.ref3"><sup>3</sup></a></td><td headers="hd_h_niceng219er1.tab2_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Qualitative, semi-structured interviews with thematic analysis</td><td headers="hd_h_niceng219er1.tab2_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
|
||
<p>Community pharmacists n=15; 11F/4M</p>
|
||
<p>Australia</p>
|
||
</td><td headers="hd_h_niceng219er1.tab2_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">To explore the views of Australian pharmacists on their roles in gout management and to identify factors influencing their involvement in gout management.</td><td headers="hd_h_niceng219er1.tab2_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Selection bias: the pharmacists were known to the researchers.</td></tr><tr><td headers="hd_h_niceng219er1.tab2_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Deprouw, 2019<a class="bk_pop" href="#niceng219er1.ref7"><sup>7</sup></a></td><td headers="hd_h_niceng219er1.tab2_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Qualitative, semi-structured interviews with grounded approach</td><td headers="hd_h_niceng219er1.tab2_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
|
||
<p>Nurses (n=20), 9 rheumatology, 11 internal medicine; and partners of gout patients n=12; 11F/1M</p>
|
||
<p>France</p>
|
||
</td><td headers="hd_h_niceng219er1.tab2_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">To explore partners’ of gout patients and nurses’ knowledge and representations of gout.</td><td headers="hd_h_niceng219er1.tab2_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Partners of gout patients and nurses</td></tr><tr><td headers="hd_h_niceng219er1.tab2_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Harrold 2010<a class="bk_pop" href="#niceng219er1.ref13"><sup>13</sup></a></td><td headers="hd_h_niceng219er1.tab2_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Qualitative, semi-structured interviews with thematic analysis</td><td headers="hd_h_niceng219er1.tab2_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
|
||
<p>Patients with gout (n=26) and providers who care for gout patients (n=15).</p>
|
||
<p>USA</p>
|
||
</td><td headers="hd_h_niceng219er1.tab2_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">To examine patients’ and health care providers’ views on the treatment of gout to better understand why management is suboptimal.</td><td headers="hd_h_niceng219er1.tab2_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Patients and health care providers</td></tr><tr><td headers="hd_h_niceng219er1.tab2_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Howren 2018<a class="bk_pop" href="#niceng219er1.ref15"><sup>15</sup></a></td><td headers="hd_h_niceng219er1.tab2_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Qualitative, semi-structured interviews</td><td headers="hd_h_niceng219er1.tab2_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
|
||
<p>Patients with gout n=12; 10 M/2 F mean age 66.5 ± 13.3 years</p>
|
||
<p>Canada</p>
|
||
</td><td headers="hd_h_niceng219er1.tab2_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">To use patients’ perspectives to construct an explanatory framework to understand how patients become engaged in the management of their gout.</td><td headers="hd_h_niceng219er1.tab2_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Patients who were participating in a proof-of-concept study (Virtual Gout Study) were recruited. Patients had a SUA>360μmol/l in the past 2 months.</td></tr><tr><td headers="hd_h_niceng219er1.tab2_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Humphrey 2016<a class="bk_pop" href="#niceng219er1.ref16"><sup>16</sup></a></td><td headers="hd_h_niceng219er1.tab2_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Qualitative, semi-structured interviews</td><td headers="hd_h_niceng219er1.tab2_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
|
||
<p>N=14 professionals who had regular interactions with patients with gout (six general practitioners (GPs), four nurses, and one pharmacist.)</p>
|
||
<p>New Zealand</p>
|
||
</td><td headers="hd_h_niceng219er1.tab2_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">To explore the experience of treating gout among primary care clinicians and understand the perceived barriers to effective therapy.</td><td headers="hd_h_niceng219er1.tab2_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">HCPs</td></tr><tr><td headers="hd_h_niceng219er1.tab2_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Jeyaruban, 2016<a class="bk_pop" href="#niceng219er1.ref17"><sup>17</sup></a></td><td headers="hd_h_niceng219er1.tab2_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Qualitative, semi-structured interviews with thematic analysis</td><td headers="hd_h_niceng219er1.tab2_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
|
||
<p>N=14 providers (GPs)</p>
|
||
<p>Australia</p>
|
||
</td><td headers="hd_h_niceng219er1.tab2_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">To explore management of gout from the perspective of GPs, while identifying the barriers and possible strategies for improvement.</td><td headers="hd_h_niceng219er1.tab2_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">GPs</td></tr><tr><td headers="hd_h_niceng219er1.tab2_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Latif, 2019<a class="bk_pop" href="#niceng219er1.ref26"><sup>26</sup></a></td><td headers="hd_h_niceng219er1.tab2_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Qualitative, semi-structured interviews</td><td headers="hd_h_niceng219er1.tab2_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
|
||
<p>Patients with gout N=30; 26M/4F Age: 65.17 (11.51) years (mean), 36–85 years (range).</p>
|
||
<p>UK</p>
|
||
</td><td headers="hd_h_niceng219er1.tab2_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">To explore patient perception of the role of a nurse-led complex package of care in facilitating engagement with urate-lowering therapies (ULTs) in the management of gout.</td><td headers="hd_h_niceng219er1.tab2_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Participants were recruited from an RCT investigating a nurse-led package of care for gout.</td></tr><tr><td headers="hd_h_niceng219er1.tab2_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
|
||
<p>Liddle, 2015<a class="bk_pop" href="#niceng219er1.ref27"><sup>27</sup></a></p>
|
||
<p>Richardson, 2016<a class="bk_pop" href="#niceng219er1.ref41"><sup>41</sup></a></p>
|
||
<p>Richardson, 2015<a class="bk_pop" href="#niceng219er1.ref42"><sup>42</sup></a></p>
|
||
</td><td headers="hd_h_niceng219er1.tab2_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Qualitative, semi-structured interviews</td><td headers="hd_h_niceng219er1.tab2_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
|
||
<p>Patients with gout N=43 67%M Age range 30–89 years</p>
|
||
<p>(Richardson 2015 n=14 age range 32 to 82)</p>
|
||
<p>UK</p>
|
||
</td><td headers="hd_h_niceng219er1.tab2_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
|
||
<p>(Richardson 2016) To explore reasons for the low prescription rate for urate lowering therapy (ULT) and the low adherence to treatment through an exploration of patient experience and understanding of ULT treatment for gout.</p>
|
||
<p>(Liddle 2015) To explore patients’ experiences from initial symptoms to receiving a diagnosis of gout.</p>
|
||
<p>(Richardson 2015) To explore the perspectives of females on receiving a diagnosis of gout and of female-specific issues related to the diagnosis.</p>
|
||
</td><td headers="hd_h_niceng219er1.tab2_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
|
||
<p>Liddle 2015 and Richardson 2016 had the same population but had different analyses performed.</p>
|
||
<p>Richardson 2015 was based a subset of female patients.</p>
|
||
</td></tr><tr><td headers="hd_h_niceng219er1.tab2_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Martini, 2012<a class="bk_pop" href="#niceng219er1.ref29"><sup>29</sup></a></td><td headers="hd_h_niceng219er1.tab2_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Qualitative, semi-structured interviews with thematic analysis</td><td headers="hd_h_niceng219er1.tab2_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
|
||
<p>Patients with gout N= 60 54M/6F Age range: 23–93 years</p>
|
||
<p>New Zealand</p>
|
||
</td><td headers="hd_h_niceng219er1.tab2_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">To explore the knowledge and perceptions of people with gout toward the disease and to determine the impact gout has on lifestyle including possible barriers to treatment.</td><td headers="hd_h_niceng219er1.tab2_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">All of the patients had been prescribed allopurinol or colchicine.</td></tr><tr><td headers="hd_h_niceng219er1.tab2_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Rebello, 2016<a class="bk_pop" href="#niceng219er1.ref40"><sup>40</sup></a></td><td headers="hd_h_niceng219er1.tab2_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Qualitative, semi-structured interviews with thematic analysis</td><td headers="hd_h_niceng219er1.tab2_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
|
||
<p>N=30 patients 24M/6F Age range 28–76 years</p>
|
||
<p>New Zealand</p>
|
||
</td><td headers="hd_h_niceng219er1.tab2_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">To explore patients’ knowledge on the use of gout medicines, and in particular their awareness of the maximum dose of colchicine, the dangers of colchicine overdose, and their opinions on restricting colchicine dispensing.</td><td headers="hd_h_niceng219er1.tab2_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Patients were from an area with a high prevalence of gout</td></tr><tr><td headers="hd_h_niceng219er1.tab2_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Seow, 2020<a class="bk_pop" href="#niceng219er1.ref46"><sup>46</sup></a></td><td headers="hd_h_niceng219er1.tab2_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Qualitative, semi-structured interviews with thematic analysis</td><td headers="hd_h_niceng219er1.tab2_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
|
||
<p>Patients with gout N=15 15M Age range 32–85 years Ethnicity: 12 Chinese, two Malay, and one Filipino</p>
|
||
<p>Singapore</p>
|
||
</td><td headers="hd_h_niceng219er1.tab2_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">To explore the perceptions regarding living with gout of patients with gout in Singapore</td><td headers="hd_h_niceng219er1.tab2_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">All participants were male</td></tr><tr><td headers="hd_h_niceng219er1.tab2_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Spencer, 2012<a class="bk_pop" href="#niceng219er1.ref53"><sup>53</sup></a></td><td headers="hd_h_niceng219er1.tab2_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Qualitative, semi-structured interviews with grounded theory analysis</td><td headers="hd_h_niceng219er1.tab2_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
|
||
<p>20 patients with gout (15M/5F) and 18 health care professionals</p>
|
||
<p>Mean age: 61 years</p>
|
||
<p>UK</p>
|
||
</td><td headers="hd_h_niceng219er1.tab2_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">To explore patient and provider illness perceptions and barriers to effective management of gout in general practice.</td><td headers="hd_h_niceng219er1.tab2_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Patients had an SUA level >360μmol/l (i.e., were sub-optimally treated)</td></tr><tr><td headers="hd_h_niceng219er1.tab2_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Te Karu, 2013<a class="bk_pop" href="#niceng219er1.ref56"><sup>56</sup></a></td><td headers="hd_h_niceng219er1.tab2_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Qualitative, semi-structured interviews with thematic analysis</td><td headers="hd_h_niceng219er1.tab2_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
|
||
<p>Maori population. N=12 67%M Age range: 48–79 years,</p>
|
||
<p>New Zealand</p>
|
||
</td><td headers="hd_h_niceng219er1.tab2_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">To explore the perceptions, understanding and treatment of gout among Maori</td><td headers="hd_h_niceng219er1.tab2_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Kaupapa Maori approach for methodology</td></tr><tr><td headers="hd_h_niceng219er1.tab2_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Vaccher, 2016<a class="bk_pop" href="#niceng219er1.ref58"><sup>58</sup></a></td><td headers="hd_h_niceng219er1.tab2_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Qualitative, semi-structured interviews with thematic analysis</td><td headers="hd_h_niceng219er1.tab2_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
|
||
<p>15 GPs (6M/9F)</p>
|
||
<p>22 patients with gout (19M/3F) Median age: 59 years</p>
|
||
<p>Australia</p>
|
||
</td><td headers="hd_h_niceng219er1.tab2_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">To explore the understanding of gout and its management by patients and general practitioners (GP), and to identify barriers to optimal gout care.</td><td headers="hd_h_niceng219er1.tab2_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Patients and GPs</td></tr><tr><td headers="hd_h_niceng219er1.tab2_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Van Onna, 2015<a class="bk_pop" href="#niceng219er1.ref59"><sup>59</sup></a></td><td headers="hd_h_niceng219er1.tab2_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Qualitative, semi-structured interviews with grounded theory analysis</td><td headers="hd_h_niceng219er1.tab2_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
|
||
<p>Patients with gout attending primary or secondary care. N=15 14M/1F Mean age 63 years</p>
|
||
<p>The Netherlands</p>
|
||
</td><td headers="hd_h_niceng219er1.tab2_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">To explore the health literacy of patients dealing with gout and to understand perceptions that might account for non-adherence to urate lowering therapy.</td><td headers="hd_h_niceng219er1.tab2_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">7 were using colchicine or NSAIDs plus ULT, 3 were using only colchicine or NSAIDs, 5 were using only ULT</td></tr></tbody></table></div></div></div><div class="whole_rhythm bk_prnt_obj"><div id="niceng219er1.tab3" class="table"><h3><span class="label">Table 3</span><span class="title">Review findings: information and support needs</span></h3><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK589578/table/niceng219er1.tab3/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__niceng219er1.tab3_lrgtbl__"><table><thead><tr><th id="hd_h_niceng219er1.tab3_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Main findings</th><th id="hd_h_niceng219er1.tab3_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Statement of finding</th></tr></thead><tbody><tr><td headers="hd_h_niceng219er1.tab3_1_1_1_1 hd_h_niceng219er1.tab3_1_1_1_2" colspan="2" rowspan="1" style="text-align:left;vertical-align:top;">Information needs</td></tr><tr><td headers="hd_h_niceng219er1.tab3_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
|
||
<p>Causes of gout</p>
|
||
<p>8 studies</p>
|
||
<p>Patients:</p>
|
||
<p>Chandratre 2016<a class="bk_pop" href="#niceng219er1.ref2"><sup>2</sup></a>, Liddle, 2015<a class="bk_pop" href="#niceng219er1.ref27"><sup>27</sup></a>, Martini, 2012<a class="bk_pop" href="#niceng219er1.ref29"><sup>29</sup></a>, Partners and nurses</p>
|
||
<p>Deprouw, 2019<a class="bk_pop" href="#niceng219er1.ref7"><sup>7</sup></a>,</p>
|
||
<p>Patients and HCPs</p>
|
||
<p>Harrold 2010<a class="bk_pop" href="#niceng219er1.ref13"><sup>13</sup></a>, Spencer, 2012<a class="bk_pop" href="#niceng219er1.ref53"><sup>53</sup></a>, Vaccher, 2016<a class="bk_pop" href="#niceng219er1.ref58"><sup>58</sup></a></p>
|
||
<p>HCPs</p>
|
||
<p>Jeyaruban, 2016<a class="bk_pop" href="#niceng219er1.ref17"><sup>17</sup></a></p>
|
||
</td><td headers="hd_h_niceng219er1.tab3_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Causes of gout were poorly understood and many alternative causes were suggested, including alternative pathophysiologies, injury and ageing.</td></tr><tr><td headers="hd_h_niceng219er1.tab3_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
|
||
<p>Dietary advice</p>
|
||
<p>8 studies (from 7 populations</p>
|
||
<p>Patients</p>
|
||
<p>Chandratre 2016<a class="bk_pop" href="#niceng219er1.ref2"><sup>2</sup></a>, Latif, 2019<a class="bk_pop" href="#niceng219er1.ref26"><sup>26</sup></a>, Liddle, 2015<a class="bk_pop" href="#niceng219er1.ref27"><sup>27</sup></a>, Martini, 2012<a class="bk_pop" href="#niceng219er1.ref29"><sup>29</sup></a>, Richardson, 2016<a class="bk_pop" href="#niceng219er1.ref41"><sup>41</sup></a>, Seow, 2020<a class="bk_pop" href="#niceng219er1.ref46"><sup>46</sup></a>,</p>
|
||
<p>Partners and nurses</p>
|
||
<p>Deprouw, 2019<a class="bk_pop" href="#niceng219er1.ref7"><sup>7</sup></a>,,</p>
|
||
<p>Patients and HCPs</p>
|
||
<p>Vaccher, 2016<a class="bk_pop" href="#niceng219er1.ref58"><sup>58</sup></a></p>
|
||
</td><td headers="hd_h_niceng219er1.tab3_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Many patients requested dietary advice, commonly wanting to know which foods and drinks were ‘safe’ and what were to be avoided.</td></tr><tr><td headers="hd_h_niceng219er1.tab3_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
|
||
<p>Long-term impact of gout</p>
|
||
<p>8 studies</p>
|
||
<p>Patients</p>
|
||
<p>Chandratre 2016<a class="bk_pop" href="#niceng219er1.ref2"><sup>2</sup></a>, Howren 2018<a class="bk_pop" href="#niceng219er1.ref15"><sup>15</sup></a>, Liddle, 2015<a class="bk_pop" href="#niceng219er1.ref27"><sup>27</sup></a>, Martini, 2012<a class="bk_pop" href="#niceng219er1.ref29"><sup>29</sup></a>, Richardson, 2016<a class="bk_pop" href="#niceng219er1.ref41"><sup>41</sup></a>, Van Onna, 2015<a class="bk_pop" href="#niceng219er1.ref59"><sup>59</sup></a></p>
|
||
<p>Partners and nurses</p>
|
||
<p>Deprouw, 2019<a class="bk_pop" href="#niceng219er1.ref7"><sup>7</sup></a>,</p>
|
||
<p>Patients and HCPs</p>
|
||
<p>Vaccher, 2016<a class="bk_pop" href="#niceng219er1.ref58"><sup>58</sup></a>,</p>
|
||
</td><td headers="hd_h_niceng219er1.tab3_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Gout is often treated as an acute condition and the long-term consequences were not frequently understood or discussed.</td></tr><tr><td headers="hd_h_niceng219er1.tab3_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
|
||
<p>Tailored information for females</p>
|
||
<p>4 studies (from 3 populations):</p>
|
||
<p>Patients</p>
|
||
<p>Liddle, 2015<a class="bk_pop" href="#niceng219er1.ref27"><sup>27</sup></a>, Martini, 2012<a class="bk_pop" href="#niceng219er1.ref29"><sup>29</sup></a>, Richardson, 2015<a class="bk_pop" href="#niceng219er1.ref42"><sup>42</sup></a>,</p>
|
||
<p>Patients and HCPs</p>
|
||
<p>Spencer, 2012<a class="bk_pop" href="#niceng219er1.ref53"><sup>53</sup></a></p>
|
||
</td><td headers="hd_h_niceng219er1.tab3_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Delays in diagnosis due to gender, poor provision of female specific information.</td></tr><tr><td headers="hd_h_niceng219er1.tab3_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
|
||
<p>Online information</p>
|
||
<p>5 studies:</p>
|
||
<p>Partners and nurses</p>
|
||
<p>Deprouw, 2019<a class="bk_pop" href="#niceng219er1.ref7"><sup>7</sup></a>,</p>
|
||
<p>Patients</p>
|
||
<p>Howren 2018<a class="bk_pop" href="#niceng219er1.ref15"><sup>15</sup></a>, Liddle, 2015<a class="bk_pop" href="#niceng219er1.ref27"><sup>27</sup></a>, Van Onna, 2015<a class="bk_pop" href="#niceng219er1.ref59"><sup>59</sup></a></p>
|
||
<p>Patients and HCPs</p>
|
||
<p>Vaccher, 2016<a class="bk_pop" href="#niceng219er1.ref58"><sup>58</sup></a>,</p>
|
||
</td><td headers="hd_h_niceng219er1.tab3_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Patients commonly searched the internet for information following diagnosis. Information online was often found to be incorrect, contradictory or ambiguous.</td></tr><tr><td headers="hd_h_niceng219er1.tab3_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
|
||
<p>Information preferences</p>
|
||
<p>8 studies (from 7 populations):</p>
|
||
<p>Patients and HCPs</p>
|
||
<p>Harrold 2010<a class="bk_pop" href="#niceng219er1.ref13"><sup>13</sup></a>, Vaccher, 2016<a class="bk_pop" href="#niceng219er1.ref58"><sup>58</sup></a>,</p>
|
||
<p>Patients</p>
|
||
<p>Latif, 2019<a class="bk_pop" href="#niceng219er1.ref26"><sup>26</sup></a>, Liddle, 2016<a class="bk_pop" href="#niceng219er1.ref27"><sup>27</sup></a>, Rebello, 2016<a class="bk_pop" href="#niceng219er1.ref40"><sup>40</sup></a>, Richardson, 2016<a class="bk_pop" href="#niceng219er1.ref41"><sup>41</sup></a>, Seow, 2020<a class="bk_pop" href="#niceng219er1.ref46"><sup>46</sup></a>, Van Onna, 2015<a class="bk_pop" href="#niceng219er1.ref59"><sup>59</sup></a></p>
|
||
</td><td headers="hd_h_niceng219er1.tab3_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Patients wanted more time for discussion during consultations, especially at diagnosis, more oral and written information and to be involved in the decision- making process.</td></tr><tr><td headers="hd_h_niceng219er1.tab3_1_1_1_1 hd_h_niceng219er1.tab3_1_1_1_2" colspan="2" rowspan="1" style="text-align:left;vertical-align:top;">Support needs</td></tr><tr><td headers="hd_h_niceng219er1.tab3_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
|
||
<p>Role of GPs</p>
|
||
<p>4 studies:</p>
|
||
<p>Patients</p>
|
||
<p>Martini, 2012<a class="bk_pop" href="#niceng219er1.ref29"><sup>29</sup></a>, Te Karu, 2013<a class="bk_pop" href="#niceng219er1.ref56"><sup>56</sup></a>#1216,</p>
|
||
<p>Patients and HCPs</p>
|
||
<p>Spencer, 2012<a class="bk_pop" href="#niceng219er1.ref53"><sup>53</sup></a>, Vaccher, 2016<a class="bk_pop" href="#niceng219er1.ref58"><sup>58</sup></a></p>
|
||
</td><td headers="hd_h_niceng219er1.tab3_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
|
||
<p>Need for improved and continuing medical education.</p>
|
||
<p>GPs felt they didn’t have enough time or appropriate material to provide to patients. Language/ cultural barriers were cited as a barrier to providing education and resulted in different understandings of gout. There was a lack of awareness of guidelines on gout. Most information was provided verbally and there was a lack of resources for providing information about gout, such as reading material, websites, and video resources.</p>
|
||
</td></tr><tr><td headers="hd_h_niceng219er1.tab3_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
|
||
<p>Role of nurses</p>
|
||
<p>3 studies:</p>
|
||
<p>Partners and nurses</p>
|
||
<p>Deprouw, 2019<a class="bk_pop" href="#niceng219er1.ref7"><sup>7</sup></a>,</p>
|
||
<p>HCPs</p>
|
||
<p>Humphrey 2016<a class="bk_pop" href="#niceng219er1.ref16"><sup>16</sup></a>,</p>
|
||
<p>Patients</p>
|
||
<p>Latif, 2019<a class="bk_pop" href="#niceng219er1.ref26"><sup>26</sup></a>,</p>
|
||
</td><td headers="hd_h_niceng219er1.tab3_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Nurses felt that with more training they would be better placed to educate and monitor patients.</td></tr><tr><td headers="hd_h_niceng219er1.tab3_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
|
||
<p>Role of pharmacists</p>
|
||
<p>2 studies:</p>
|
||
<p>Pharmacists</p>
|
||
<p>Counsell, 2018<a class="bk_pop" href="#niceng219er1.ref3"><sup>3</sup></a>,</p>
|
||
<p>Patients</p>
|
||
<p>Martini, 2012<a class="bk_pop" href="#niceng219er1.ref29"><sup>29</sup></a></p>
|
||
</td><td headers="hd_h_niceng219er1.tab3_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Pharmacists had a good understanding of medication related issues and of dietary information. Able to ‘bridge the gap’ between patient and GP due to having more time. Opportunity to offer information at each prescription.</td></tr><tr><td headers="hd_h_niceng219er1.tab3_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
|
||
<p>Referral to specialists</p>
|
||
<p>5 studies (from 4 populations):</p>
|
||
<p>Partners and nurses</p>
|
||
<p>Deprouw, 2019<a class="bk_pop" href="#niceng219er1.ref7"><sup>7</sup></a>,</p>
|
||
<p>Patients and HCPs</p>
|
||
<p>Harrold 2010<a class="bk_pop" href="#niceng219er1.ref13"><sup>13</sup></a>,</p>
|
||
<p>Patients</p>
|
||
<p>Liddle, 2015<a class="bk_pop" href="#niceng219er1.ref27"><sup>27</sup></a>, Richardson, 2016<a class="bk_pop" href="#niceng219er1.ref41"><sup>41</sup></a>, Seow, 2020<a class="bk_pop" href="#niceng219er1.ref46"><sup>46</sup></a></p>
|
||
</td><td headers="hd_h_niceng219er1.tab3_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">A variety of views on specialist referral were found, both from patients, family/ friends and their GPs.</td></tr></tbody></table></div></div></div></div><div><p>Final version</p></div><div><p>Evidence reviews underpinning recommendations 1.2.1 and 1.2.2 in the NICE guideline</p><p>National Institute for Health and Care Excellence</p></div><div><p><b>Disclaimer</b>: The recommendations in this guideline represent the view of NICE, arrived at after careful consideration of the evidence available. When exercising their judgement, professionals are expected to take this guideline fully into account, alongside the individual needs, preferences and values of their patients or service users. The recommendations in this guideline are not mandatory and the guideline does not override the responsibility of healthcare professionals to make decisions appropriate to the circumstances of the individual patient, in consultation with the patient and/or their carer or guardian.</p><p>Local commissioners and/or providers have a responsibility to enable the guideline to be applied when individual health professionals and their patients or service users wish to use it. They should do so in the context of local and national priorities for funding and developing services, and in light of their duties to have due regard to the need to eliminate unlawful discrimination, to advance equality of opportunity and to reduce health inequalities. Nothing in this guideline should be interpreted in a way that would be inconsistent with compliance with those duties.</p><p>NICE guidelines cover health and care in England. Decisions on how they apply in other UK countries are made by ministers in the <a href="http://wales.gov.uk/" ref="pagearea=body&targetsite=external&targetcat=link&targettype=uri">Welsh Government</a>, <a href="http://www.scotland.gov.uk/" ref="pagearea=body&targetsite=external&targetcat=link&targettype=uri">Scottish Government</a>, and <a href="http://www.northernireland.gov.uk/" ref="pagearea=body&targetsite=external&targetcat=link&targettype=uri">Northern Ireland Executive</a>. All NICE guidance is subject to regular review and may be updated or withdrawn.</p></div></div></div>
|
||
<div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © NICE 2022.</div><div class="small"><span class="label">Bookshelf ID: NBK589578</span><span class="label">PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/36921074" title="PubMed record of this title" ref="pagearea=meta&targetsite=entrez&targetcat=link&targettype=pubmed">36921074</a></span></div></div></div>
|
||
|
||
</div>
|
||
</div>
|
||
</div>
|
||
<div class="bottom">
|
||
|
||
<div id="NCBIFooter_dynamic">
|
||
<!--<component id="Breadcrumbs" label="breadcrumbs"/>
|
||
<component id="Breadcrumbs" label="helpdesk"/>-->
|
||
|
||
</div>
|
||
|
||
<script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js"> </script>
|
||
</div>
|
||
</div>
|
||
<!--/.page-->
|
||
</div>
|
||
<!--/.wrap-->
|
||
</div><!-- /.twelve_col -->
|
||
</div>
|
||
<!-- /.grid -->
|
||
|
||
<span class="PAFAppResources"></span>
|
||
|
||
<!-- BESelector tab -->
|
||
|
||
|
||
|
||
<noscript><img alt="statistics" src="/stat?jsdisabled=true&ncbi_db=books&ncbi_pdid=book-toc&ncbi_acc=NBK589578&ncbi_domain=niceng219er1&ncbi_report=printable&ncbi_type=fulltext&ncbi_objectid=&ncbi_pcid=/NBK589578/?report=printable&ncbi_app=bookshelf" /></noscript>
|
||
|
||
|
||
<!-- usually for JS scripts at page bottom -->
|
||
<!--<component id="PageFixtures" label="styles"></component>-->
|
||
|
||
|
||
<!-- CE8B5AF87C7FFCB1_0191SID /projects/books/PBooks@9.11 portal107 v4.1.r689238 Tue, Oct 22 2024 16:10:51 -->
|
||
<span id="portal-csrf-token" style="display:none" data-token="CE8B5AF87C7FFCB1_0191SID"></span>
|
||
|
||
<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4216699/js/3879255/4121861/3501987/4008961/3893018/3821238/3400083/3426610.js" snapshot="books"></script></body>
|
||
</html> |